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ABSTRACT 
TREATMENT DECISION MAKING IN AFRICAN AMERICAN WOMEN 
DIAGNOSED WITH ADVANCED BREAST CANCER 
 
by 
Dauphne Annette Sims 
The University of Wisconsin-Milwaukee 2014 
Under the Supervision of Professor Dr. Jennifer J. Doering 
 
  
When diagnosed with breast cancer African American women have 
more advanced stage breast disease and encounter disparities 
throughout the cancer care continuum. The process of making treatment 
decisions can widen or narrow disparities in health outcomes. The 
decision making process in African American women may be influenced 
by several dynamics that influence how treatment decisions are made 
and have been previously unexplained. Guided by the conceptual 
framework of Cultural Capital, this grounded theory study explored the 
treatment decision making process of 12 African American women who 
were diagnosed with advanced (stages II-IV) breast cancer. The basic 
social process of Fortitude in Treatment Decision Making emerged from 
the data. Fortitude described an internal process that participants 
garnered to make treatment decisions and face the breast cancer 
journey. Utilizing Fortitude, participants described a treatment decision 
making process that included getting the diagnosis, communication with 
their physician, choosing a decisional pathway, and physician trust 
and/or mistrust that facilitated them in making treatment decisions. 
iii 
 
This study provides nurses with a more thorough understanding of the 
decision making process in African American women facing advanced 
stage breast cancer.  
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Chapter One 
The Problem 
 
 Decision making is a multifaceted phenomenon (Broadstock & 
Michie, 2000). There are many decisions that any woman would need to 
make once diagnosed with a life threatening disease. Yet, grasping what 
the decision making process is for African American women who are 
facing advanced breast cancer is complex. For example, African-
American women are diagnosed at a later stage and therefore have more 
complex options to consider than their white counterparts (American 
Cancer Society [ACS], 2013). African-American women are more likely to 
die sooner (ACS, 2013), which means that poorly made treatment 
decisions have more dire consequences for African-American women’s 
survival and quality of life. In addition, persistent health disparities make 
this process more daunting.  A most important fact is that treatment 
decisions for African American women are not well understood. 
Therefore, the purpose of this study was to generate a substantive theory 
of the treatment decision making process of African American women 
who have been diagnosed with stage II to IV breast cancer. 
 The ability to make appropriate and informed decisions about 
breast cancer treatment can ultimately affect a woman’s disease course, 
morbidity, and mortality (Hawley et al., 2007). A fundamental principle of 
decision making is autonomy and informed choice (O’Brien et al., 2008). 
In addition, patient involvement in medical decision-making refers to the 
ability and willingness of the patient to be an active participant in his or 
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her care (Gordon, 2002). A woman’s ability to make informed decisions is 
imperative to her long term treatment outcomes with breast cancer 
(O’Brien et al., 2008). In the past, decision making was limited to 
clinical-decision making by health professionals (Broadstock & Michie, 
2000). However, there has been a shift in the decision making paradigm 
where patient empowerment involves patient participation in their 
healthcare (Johnston Polacek, Ramos & Ferrer, 2007). For African 
American women, participation in breast cancer treatment decision 
making is linked to racial disparities throughout the cancer care 
continuum (Johnston, et al.; McVea, Minier, & Johnson Palensky, 2001; 
Shootman, Jeffe, Gillanders, & Aft, 2009). 
 The stage of disease at diagnosis is an important factor in the 
decision making process related to treatment in African American 
women. African American women present more often with late stage 
breast cancer disease (Adams et al., 2009; Short et al., 2009). This 
makes treatment decisions even more complex for all women (Halkett, 
2007). The median survival after diagnosis of metastatic breast cancer, 
based on research by Chia et al. (2007) is around 24 months. Because of 
this short survival time frame women with advanced disease are likely to 
die sooner than later. Although there are several therapies for advanced 
breast cancer, decision making is especially complex in these cases due 
to the uncertainty of whether to further active treatment or to switch to 
supportive care (Sepucha, Ozanne, Partridge, & Moy, 2009). Smith (2008) 
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points out that “the right decisions are important to ensure that the 
patient achieves not just optimum survival but survival with as much a 
quality of life as possible” (p.51).    
 According to research findings, late-stage diagnosis in African 
American women is linked with a number of disparities including: 
inadequate access to care, lack of access to health information, and 
misconceptions about treatments (ACS, 2010). Most notably, African 
American women experience delays in receiving care once diagnosed with 
breast cancer (Ciamboone, 2006; Halpern, Chen, Marlow, & Ward, 2009; 
Onega, Duell, Shi, Demidenko, & Goodman, 2010) and they are less 
likely to receive standard treatment therapy than Caucasian women 
(Johnston Polacek et al., 2007; Shootmen et al., 2009).   
 Decision making in breast cancer comprises a series of steps or 
processes of decisions that need not be linear but reflect a woman’s 
preferences and values (Mohamed, Williams, Tamburrino, Wryobeck, & 
Carter, 2005). How this is done with African American women is not well 
understood. Yet, it is clear that there is a gap in the literature regarding 
how African American women engage in treatment decision making. 
Treatment decision making in African American women needs to be 
addressed from initial information needs to decisions regarding adjuvant 
therapies. It is important to consider the disparity in breast cancer death 
rates between African American women and all other ethnic groups. 
Filling this gap would help to reduce health disparities in mortality in 
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African American women as well promote quality of life for those women 
who ultimately choose palliative care. Therefore, it is imperative to 
explore the issues of decision making in African American women. The 
disparities surrounding treatment, specifically misconceptions and the 
lack of knowledge regarding appropriate treatment options (ACS, 2010), 
delays in treatment ((Ciamboone, 2006; Halpern, Chen, Marlow, & Ward, 
2009; Onega, Duell, Shi, Demidenko, & Goodman, 2010), and the lack of 
empowerment perceived by African American women to participate in the 
decision making process are central to how late-stage disease is 
approached by the woman (Fagerlin et al., 2006; Hawley et al., 2009). 
Purpose 
 Given that the purpose of this study was to generate a substantive 
theory of the treatment decision making process of African American 
women were diagnosed with stage II to IV breast cancer, it was 
imperative to gain understanding of their process of decision making.  In 
addition, understanding the process of decision making in this group of 
women may aid health care providers to develop interventions and health 
care practices that may eventually reduce health disparities and promote 
quality of life for women and families facing this challenging illness. 
Moreover, a grounded theory will provide the insight into the 
complexities, types, and levels of decision making needed to address the 
immediate concerns of being diagnosed with advanced breast cancer. 
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Background and Significance  
 Phenomenon and Complexities of Decision Making 
 Decision making is a multifaceted process that includes decisional 
roles and preference, health care and patient communication styles, and 
information needs. Research performed by Ashing-Giwa et al. (2004) 
illustrated the challenges women (African American n=5; Asian American 
n=5; Caucasian n=4; and Latina n=6) experience managing with a breast 
cancer diagnosis including: lack of knowledge; medical issues such as 
insurance, cost and amount of time spent with physicians; cultural 
sensitivity of providers; language barriers; cultural factors related to 
beliefs about illness, gender role and family obligations.  Fagerlin et al. 
(2006) point out that patient education is needed to ensure women of all 
ethnicities are able to make informed decisions regarding their care. 
Maly, Umezawa, Leake and Silliman (2004) stress that patient self-
efficacy is a powerful predictor in how women participate in decision 
making with physicians, based on their work with women from all 
ethnicities.  
 Patient focused decisions involve patient autonomy and self-
determination as part of the process (Broadstock & Michie, 2000). 
Denger et al. (1997) found, in their research, that a majority (66%) of 
Caucasian women wanted a substantial degree of involvement in making 
treatment decisions. Yet, there was a significant percent of the sample 
(34%) who wanted to delegate the decision making responsibility to their 
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physician. Moreover, other studies found similar results of a division 
between patient autonomy and the patients’ desire for decisional 
involvement, with some patients choosing not to be active participants 
and assuming passive roles (Maly et al., 2004; Robinson & Thomson, 
2001). Vogel, Helmes and Hasenburg (2008) found that newly diagnosed 
German breast cancer patients preferred the physician to make 
treatment decisions. Alternatively, Lantz et al. (2005) found that high 
satisfaction with decisional involvement was associated with higher levels 
of education and income, being married, and being white. Comparatively, 
minority women (African American and Latina) with low incomes were 
more likely to have low satisfaction or decisional regret with treatment 
decision making. Similarly, Hawley et al. (2007) found that the desire for 
treatment involvement varied according to the patient age, race, and/or 
educational status. Research by Hack, Denger, Watson, and Sinha 
(2006) showed that as Caucasian women progress along their breast 
cancer trajectory, they are inclined towards a more active and 
collaborative involvement in the care. However, the women who preferred 
a more passive role did so at the time immediately following surgery, 
around the time of adjuvant treatment planning, and follow-up.  Hawley 
et al. (2009) linked race and decisional involvement and the role of others 
(spouse, family or friends) and found that African American women were 
least likely to indicate their spouse as important to their decision 
making. This is in direct contrast to research by Fowler (2006b) who 
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found that family and kinship ties are extremely important to African 
American women in decision making. 
Illness and Decision Making 
 Classical theories of decision making presume that people have 
well expressed values and preferences that guide their decisions, 
(McCaul, Peters, Nelson, & Stefanek, 2005) and that people will make 
rational decisions (Betsch, Haberstroh, & Hohle, 2002). However, people 
confronting cancer are often in a state of information overload where they 
feel overwhelmed with information, options and choices (McCaul et al., 
2005). Work by Vogel, Bengel, and Helmes (2008) show that many 
German women want a great amount of specific information concerning 
their illness and treatment. Conversely, Fagerlin et al. (2006) found that 
the majority of their participants did not have the level of knowledge 
commensurate with making an informed decision and that for the 
sample, African American women (24.2%) had less knowledge about their 
breast cancer treatment than white women (51.5%). Research by Hack, 
Denger and Dyck (1994) found Caucasian patients who were active in 
their decision making wanted more information and those who were 
passive in their decision making wanted minimal information.  
 Decision making is conceptualized differently depending on the 
discipline examining the concept. Behavior theorists discuss decision 
making as rational decisions that involve analytic decision making where 
decisional aids are utilized to help formulate solutions (Sepucha et al., 
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2009). From another perspective, decision making, is thought to be 
problem based, where potential solutions are based on a person’s 
available routine.  Routine is defined as a set of prior behaviors or 
behavioral knowledge in which the person has learned a particular set of 
solutions (Betsch et al., 2002). This perspective views one’s decision 
making as based on prior developed habits that allow people to 
implement decisions automatically. Furthermore, this type of decision 
making is not predicated on prior personal experience; instead, it can be 
learned by observation (Betsch et al.). Literature from a medical model 
perspective suggests that decision making involves including the patient 
in shared and informed decision making processes (Robinson & Thomas, 
2001; Rimer, Briss, Zeller, Chan & Woolf, 2004; Whitney et al., 2008). 
Still other literature, from a systems perspective, describes decision 
making as an iterative process where one decision leads to another and 
decisions are revisited and changed based on the flow of information 
(Fowler, 2006a; Halkett, Arbon, Scutter & Borg, 2007). 
Treatment Decision Making 
 The few studies that have examined treatment decision making in 
African American women have focused solely on early stage breast cancer 
(Hawley et al., 2007; Lackey, Gates & Brown, 2001; Maly, Umezawa, 
Ratliff, & Leake, 2006). Maly et al., found that older African American 
women often reported themselves as the primary decision maker. 
Conversely, these authors found that acculturated Latinas reported 
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family members were the final decision makers, more so than African 
American and Caucasian women. Only one study specifically researched 
the information needs of African American women with early breast 
cancer. These investigators found this group lacked the knowledge to 
make informed decisions (Fagerlin et al., 2006). However, research by 
Denger et al. (1997) regarding informational needs and decisional roles of 
women with breast cancer further clarified what informational needs may 
be lacking. The highest priority information needs for these Caucasian 
women were chances of cure and spread of the disease. Treatment 
options and family risk were in the next level of priority.  The women 
cited adverse effects, home self-care, impact on family, and social 
activities in the medium level of priority.  Finally the lowest priority cited 
was sexuality.  Two investigators looked specifically at race and the 
mastectomy as a surgical treatment decision for women with early stage 
disease (Hawley et al, 2009; Katz et al., 2005). Information from the 
research by Katz et al. was illuminating because they found disparities 
with surgeons and their recommendations for breast conserving surgery 
(BCS). The surgeons in the study placed less emphasis on BCS when 
describing surgical options and making recommendations about surgery 
to African American women compared to Caucasian women. On the other 
hand Hawley et al. (2009) found that when minority women (African 
American and Latina) had greater patient involvement in decision making 
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this influenced their surgical decision making toward having a 
mastectomy. 
Advanced Stage Breast Cancer  
 There is a gap in the literature regarding African American women 
with advanced stage breast cancer, specifically stages II to IV. There are 
numerous factors that are involved in making treatment decisions at this 
level: prior adjuvant therapy; hormone receptors; human epidermal 
growth factor receptor 2 (HER2) status; patient characteristics; response 
to prior chemotherapy; patient preference; re-biopsy and formal 
guidelines (Genetech, 2009).  Research by Rosenzweig, Wiehagen, 
Brufsky, and Arnold (2009) explored how race and income status 
influence women’s experiences with advanced breast cancer. They found 
that there were unique experiences for low-income African American 
women that implied greater physical and social distress and less 
understanding of illness and treatment goals. The women specifically 
verbalized a lack of knowledge regarding treatment efficacy and described 
some frustration in their attempts to find information regarding their 
health status and treatment goals.  
Definition of Advanced Cancer 
The American Joint Committee on Cancer (AJCC) has specific 
guidelines on how to stage breast cancer tumors. Staging is based on 
commonly understood knowledge about the way cancer develops and 
spreads (American Joint Committee on Cancer, 2014). Staging is based 
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on four main factors: a) location of the primary tumor a) tumor size c) 
lymph node involvement and d) the presence or absence of distant 
metastasis. The staging system is referred to as Tumor, Node and 
Metastasis (TNM) and goes from 0 to IV. It is also further delineated 
within each staging group (see Table 1). Advanced stage breast cancer is 
defined as stage IIB to IV (AJCC, 2014; Breastcancer.org, 2014; 
Genetech, 2009). Women with metastatic breast cancer are defined has 
having advanced staged breast cancer. 
Table 1 
 
Breast cancer staging 
 
Stage of breast cancer Staging Characteristics 
Stage I Tumor is no larger than 2 cm 
Stage IIA Tumor measure up to 2cm; no lymph 
node involvement; no distant 
metastasis 
Stage IIB Tumor is larger than 5 cm but has not 
spread to the axillary lymph nodes; Or 
tumor is larger than 2 cm but not larger 
than 5 cm; multiple lymph node 
metastasis;   
Stage IIIA Tumor is larger than 5 cm with multiple 
metastasis to the lymph nodes  
Stage IIIB Tumor may be any size with metastasis 
to the chest wall or has caused swelling 
or ulceration of the breast; multiple 
lymph node metastasis   
Stage IIIC A tumor of any size with multiple lymph 
node metastasis (above and below the 
clavicle; the tumor has not spread to 
distant parts of the body 
Stage IV A tumor of any size with multiple 
metastasis of lymph nodes and distant 
metastasis to the brain, lung, liver, and 
bone.  
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Patient-Physician Communication 
 Research about physician and patient communication has been 
well documented (Charles, Gafni, & Whelan, 2004; Maly, Stein, 
Umezawa, Leake, & Anglin, 2008; Nekhlyudov & Braddock, 2009). There 
was only one study that specifically looked at treatment decision making 
regarding patient physician communication in African American women 
(N=39; Royak-Schaler et al., 2008).  These investigators found there were 
significant gaps in communication which can perpetuate misinformation.  
For example, 38 percent of the women were unaware of their stage of 
disease at diagnosis, 5 percent did not know which type of surgery they 
had undergone, and 31 percent never received either chemotherapy or 
radiation, even though it was indicated.  Only 50 percent of women 
stated that their physician discussed treatment side effects with them.  
Finally, while 75 percent of the women reported that their primary 
source of information was their physician, they reported not receiving 
information on surveillance, symptoms after treatment and prevention of 
recurrence (Royak-Shaler et al., 2008). McVea et al. (2001) examined the 
patient physician relationship and low income women (N=25) with early 
stage breast cancer disease. They found that the patient physician 
relationship and the patient’s emotional response to the diagnosis of 
cancer had a tremendous impact on the process of treatment decision 
making. Moreover, low income women did not perceive they had an 
opportunity for true informed decision making (McVea et al., 2001).  
13 
 
 
 
Breast Cancer Disparities  
 Barriers for African American women are reported in the literature 
throughout the breast cancer care continuum (Halpern et al., 2009; 
Johnston Polacek et al., 2007; Shootman et al., 2009).  Among early 
stage breast cancer patients, Halpern et al. found that African American 
women (N=1992) were significantly more likely not to receive lymph node 
biopsy (LNB) than were Caucasian patients. Likewise, older patients ages 
62 to 72 were more likely not to receive LNB than younger patients. At 
the other end of the continuum, Shootman et al., attempted to explain 
racial disparities in the development in metastases. These investigators 
found that African American women were more likely to be diagnosed 
with more advanced disease and with estrogen receptive (ER) negative 
and progesterone receptive (PR) negative breast cancers. In addition, 
African American women were more likely to develop metastases and be 
low-income than Caucasian women. 
 Additional barriers range from poor physician patient 
communication to disparities with age, income and disease state (McVea 
et al., 2001). In addition there are disparities in information sharing and 
coordination of follow up care plans (Royak-Schaler et al., 2008).  Other 
barriers include incongruence with decisional roles and actual and 
preferred levels of involvement in decision making (Vogel, Helmes, et al., 
2008; Hack et al., 2006). Some of the most important barriers are with 
treatment decision making especially with advanced breast cancer 
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disease (Sepucha et al., 2009).  These investigators examined white 
women (N=32) with advanced breast cancer and assessed their decision 
making regarding using a decisional aid, decisional conflict, participation 
in decisions, and their treatment goals, experience and preferences.  
They found that the decisional aid was helpful. The women preferred a 
shared decision making style versus having the doctor make the 
decisions. However, ninety percent of the women felt that the main goal 
of treatment was to prolong life, given the lack of medical evidence for 
survival benefit (Sepucha et al., 2009).  
Significance to Nursing Research 
 The way to begin to address the mortality issue in breast cancer 
with African American women is with nursing research.  Nurses possess 
the training and skills to be able to design specific culturally competent 
research to facilitate knowledge development in this population of 
women.  Nursing is the one common thread connecting the women 
throughout their journey with breast cancer from detection through 
survivorship. One way this is realized is through use of breast cancer 
“navigators” who are nurses who provide resources across time to help 
women manage the disease (Simon, 2013).  In addition, oncology nurses 
play an integral role in advocating for breast cancer patients. 
Part of the American Nurses Association six essential features of 
professional nursing is the provision of a caring relationship that 
facilitates health and healing (American Nurses Association [ANA], 2003).  
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In addition, nursing’s application of scientific knowledge to the processes 
of diagnosis and treatment through the use of judgment and critical 
thinking is another essential need that is pertinent to this study’s 
population of women (ANA, p.5).  Nursing is at the forefront of fostering 
patient communication, providing support, and answering the questions 
that women have regarding breast cancer. In other words, nursing plays 
a key role in decision making. And, it is in this role that nursing needs to 
be better prepared and confident in assisting women making decisions 
about breast cancer care. The gaps in the literature on decision making 
in African American women with advanced breast cancer puts nurses in 
an ideal position to generate knowledge in this area.  
Conceptual Framework 
Cultural Capital  
 This study used the theoretical perspective of cultural capital to 
better understand the influence of culture, society, and economic factors 
on African American women and their decision making.  The term 
cultural capital is broadly defined as people’s symbolic and informational 
resources for action (Bourdieu, 1986). Those resources are forms of 
knowledge, operational skills, linguistic styles, values, norms, education, 
and advantages that a person has acquired through life long socialization 
(Abel, 2008). This sociologic framework by Bourdieu and Passeron 
facilitated the emergence of cultural capital as a conceptual tool for 
understanding social differentiation (Robbins, 2005). 
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 Cultural capital can exist in three forms: in the embodied state (a 
form of long-lasting dispositions of the mind and body); in the objectified 
state, in the form of cultural goods (books, instruments, pictures etc.); 
and in the institutionalized state (educational degrees and professional 
titles; Bourdieu, 1986).  It is expressed through habitus, a person’s ways 
of acting, feeling, thinking and being which is shaped by ones’ past and 
present circumstances (Bourdieu, 1990). The equalities and/or 
inequalities of cultural capital are expressed in the social arena and 
milieu’s (fields) in which people navigate on a daily basis (Bourdieu, 
1986). Bourdieu (1990) defines ‘field’ as the social space in which 
interactions, transactions, and events occur. Given this definition, this 
theory creates a framework for how cultural practices contribute to social 
arenas and how these social spaces affect cultural practices and 
decisions. In terms of healthcare, class-related cultural resources 
interact with economic and social capital to form people’s health 
decisions (Abel, 2008).  
 When applied to healthcare research, cultural capital can be used 
to define health relevant culture-based resources that are available to 
people to act in favor of their health (Abel, 2008). For example, cultural 
capital is linked to how African American women incorporate health 
knowledge as a resource for promoting their health (Abel, 2008). 
Linguistic capital, a form of embodied cultural capital, represents a 
means of communication and self-presentation acquired from one’s 
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surrounding culture. This can play a significant role in how African 
American women communicate with healthcare providers.  
 There is a plethora of literature regarding the healthcare system in 
the United States and the inequalities in services, which includes the 
Institute of Medicine (2010) report on the disparities in healthcare. One  
of the disparities outlined in this report involves race and ethnicity. 
Therefore, it is important to explore the cultural perspectives of African 
American women and their decision making.  The theoretical perspective 
of cultural capital will provide a context for understanding how cultural 
practices influence African American women’s decision making in their 
social field(s) and within the field of the healthcare system. 
Background and Use of a Cultural Capital Perspective  
  The French sociologist Pierre Bourdieu developed the concept of 
cultural capital in the 1960’s to address the disparities in education of 
children from different social classes (Weininger & Lareau, 2007).  
Bourdieu posited that economic factors alone did not account for the 
difference, but that cultural habits and dispositions inherited from family 
were important as well (Bourdieu, 1986). Bourdieu maintained that 
culture shares many of the properties that are characteristic of economic 
capital, in that, cultural habits and dispositions comprise a resource 
capable of generating profits. Furthermore, he asserted that they can be 
transmitted from one generation to the next (Weininger & Lareau, 2003). 
Bourdieu’s work used the notion that culture is directly implicated in 
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social inequality and that classes are differentiated from one another in 
terms of the overall volume of capital (economic plus cultural) controlled 
by individuals or families (Weininger & Lareau, 2007).  
 It is important to note that economic, social, and cultural capitals 
are interrelated fluid concepts that may help describe people’s health 
through individual patterns of interactions; specifically the different 
forms of cultural capital can provide a context for understanding the 
differences in healthcare decisions, interactions, and treatment options. 
Shim (2010) defines a new concept called cultural health capital, based 
on Bourdieu work, which would help account for how patient provider 
interactions unfold in ways that may generate disparities in healthcare, 
specifically that while interaction styles might be non-purposeful, they 
are culturally-mediated and habitual. Similarly, Abel (2008) expresses 
the need for conceptualized cultural capital in healthcare research, 
particularly in relating cultural capital to healthcare inequalities based 
on the different forms as outlined by Bourdieu. 
Cultural Capital and Decision Making in African American Women 
with Advanced Breast Cancer  
 This theory can be adapted to understanding decision making in 
African American women because the underlying theme of cultural 
inheritance (social and economic) is multifaceted and dynamic (Abel, 
2008; Bourdieu, 1990). African American women may respond differently 
in healthcare situations based on their level of social or economic capital. 
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African American women who are limited in social capital may not 
interact fully with their healthcare provider and leave the encounter with 
unanswered questions, thus making uninformed decisions. In addition, 
this theory purports that capital can be obtained if a person is willing to 
work at it (Bourdieu, 1986). This proposition could provide a context to 
glean information on what cultural resources are needed to facilitate 
African American women in their decision making, which could inform 
future intervention development to reduce disparities. Moreover, this 
theory also could be utilized to explore the context of ‘fields’ in 
healthcare, specifically the use of power demonstrated by the healthcare 
provider and how this perceived use of power influences decision making. 
In addition, this theory could also assist in describing how the 
interaction within social fields involving family and friend’s influence 
decision making and how decisions can evolve over time.   
Research Questions 
The research questions that guided this study were as follows: 
1. How do African American women with advanced breast cancer 
describe their process of making decisions about treatment? 
 a. How do women participate in treatment decisions? 
b. How is a woman’s participation in their treatment decisions 
facilitated? 
c. How is a woman’s participation in their treatment decision 
hindered? 
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d. How do women describe their patient-health care provider 
communication and interaction in relation to treatment decision 
making? 
e. What additional resources do they utilize in making their 
treatment decision? 
2. What factors of cultural capital do women utilize when making 
treatment decisions? 
 a. What social supports do women utilize when making treatment 
 decisions? 
b. How do economic circumstances affect treatment decision 
making? 
c. How do important cultural values or beliefs influence women 
when  making treatment decisions? 
 d. How do cultural concerns influence their treatment decisions? 
Chapter Summary 
 Breast cancer is the second most common cause of death in 
African American women. When diagnosed with breast cancer African 
American women have more advanced stage breast disease and 
encounter disparities throughout the cancer care continuum. The ability 
to make informed decisions about breast cancer treatment can ultimately 
affect a woman’s disease trajectory and mortality. One way to address 
the increased mortality is explore the cultural aspects of treatment 
decision making of African American women.  
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Chapter Two 
 Review of Literature 
 This chapter will provide a comprehensive review of the breast 
cancer decision making literature. Breast cancer treatment research has 
provided new options for women making decisions regarding their breast 
cancer diagnosis. However, disparities in mortality continue for African 
American women for a myriad of reasons. The following literature review 
will examine: 
 Health disparities in breast cancer, and 
 Decision making processes 
A summary of literature in each of these areas including identification of 
gaps in knowledge will be provided. In addition an overview and analysis 
of the pilot study conducted are provided. 
Health Disparities in Breast Cancer 
 The disparities in health care for African American women are well 
documented (Halpern et al., 2009; Johnston Polacek et al., 2007; 
Shootman et al., 2009).  There is compelling literature regarding 
disparities with African American women and breast cancer. The 
following areas that will be addressed are racial differences in tumor size 
and lymph nodes biopsy, diagnosis and treatment, the factors of race 
and insurance, and patient healthcare provider communication.  
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Disparities in Tumor Size and Lymph Nodes Biopsy 
 McBride et al. (2007) examined the biology of tumor size and stage 
of breast cancer along with the number of positive axillary lymph nodes 
and distant metastasis. Logistic regression models were developed for 
African American and white women diagnosed with stage I-III breast 
cancer. These women were identified through the Surveillance 
Epidemiology and End Results (SEER) program (African American 
women n= 21,861 and Caucasian women n=234,313). The SEER registry 
provided information regarding stage of disease; tumor grade, size and 
histology; lymph node status and overall survival of each patient.  
The results showed African American women tumor sizes were 
significantly larger than Caucasian for women (2.5 cm versus 1.6). There 
were significantly more positive lymph nodes for African American 
women than for Caucasian women (4.3 vs 4.0). Across the range of 
tumor stages African American women had fewer stage I tumors (52.2%) 
than Caucasian women (65.9%) and African American women had 
significantly more stage II tumors than Caucasian women (40.4% vs 
30.1%). In addition African American women had significantly more stage 
III tumors (7.4%) than Caucasian women (4.0%). They also found that 
tumor stage and race have a significant interaction with the mortality 
rate. There were racial disparities in survival rates between African 
American and Caucasian women: as stage at diagnosis increased, the 
racial disparity in survival also increased. Most importantly, African 
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American women had a 39 percent higher mortality rate than Caucasian 
women (McBride et al.).  
 Reeder-Hayes et al. (2011) evaluated the differences in the use of 
sentinel lymph node biopsy (SLNB) by age and race in Medicare patients 
with early breast cancer (stages I-II). Multivariable linear modeling was 
used to calculate the odds of receiving SLNB. Caucasian  (n=3574) and 
African American (n=300) women who received breast conserving surgery 
including axillary staging with claims from 12 months before diagnosis to 
24 months after diagnosis were identified through the SEER Medicare 
database. These investigators found in an unadjusted analysis across all 
years, African American women were half as likely as Caucasian women 
to receive SLNB (OR .54, 95% CI, 0.42-.069). In an adjusted analysis 
African American women were significantly less likely to receive SLNB 
than Caucasian patients (OR=.65, 95% CI, 0.57-0.87). Women enrolled in 
Medicaid had significantly lower odds of receiving the procedure 
(OR=0.61, 95% CI, 0.47-.078). Tumor characteristics were significantly 
associated with use of SLNB and overall women with lower risk tumor 
characteristics were more likely to receive SLNB. Specifically, that women 
with stage I or IIA tumors were more likely to have under SLNB than 
those with IIB tumors. The use of SLNB varied significantly by institution 
over time. Treatment at a cooperative group affiliated institution was 
associated with higher odds of receiving SLNB (OR 2.31, 95% CI, 1.50-
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5.61). However, there was no significant interaction found between 
institutional characteristics and race. 
Critique. These two articles highlight the disparities associated 
with lymph node biopsy with African American women being less likely 
than Caucasian women to have their lymph nodes removed, which is an 
important part of staging and diagnosis. One of the limitations noted of 
these studies was that there was no evaluation of the differences in 
treatment across the various stages of breast cancer.  The aggressiveness 
of how these cancers were or were not treated has implications for 
mortality rates. However, these two studies confirm that lymph node 
removal and diagnosing is important especially for more advanced stages 
of breast cancer and tumor sizes. Another limitation noted was the small 
sample sizes (McBride et al., 2007; Reeder-Hayes, 2011) for African 
American women. The implication of race and institutional factors of 
affiliation with cooperative research groups and institutional polices that 
prevented performing lymph node biopsies were important 
considerations. The differences in how institutions treat breast cancer 
patients is an avenue of exploration regarding quality of care and 
outcomes. Neither groups of investigators looked at whether women 
made treatment decisions based on tumor sizes or lymph node biopsies. 
Finally, the finding that having Medicare does not seem to account for or 
explain the disparities in this area is an important finding. 
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Disparities in Diagnosis and Treatment  
 Williams et al. (2010) examined the factors associated with delays 
to diagnosis and treatment of breast cancer. Logistic regression, chi-
square test, and Wilcoxon signed rank test, were used on a sample of 
African American women (n=195) and Caucasian women (n=43). This 
analysis was based on two data sets: Louisiana tumor registry (LTR) and 
Medical Center of Louisiana at New Orleans (MCLNO) electronic medical 
record extraction. The LTR contained statewide population based data on 
all newly diagnosed cancers. The MCLNO contained individual patient 
information (demographics, personal information, visits, patient history, 
laboratory, pathology and radiology results). Other criteria for the 
analysis were: Late stage disease, stages III-IV; Time from abnormality to 
diagnosis (the number of days from the date of the detection of the first 
abnormality to the date of the diagnosis); Time from diagnosis to initial 
treatment (the number of days from the date of the diagnosis to the date 
of the initiation of treatment); Date of Diagnosis (the date of initial 
diagnosis by a medical practitioner); and Treatment type (surgery, 
chemotherapy, radiation, other, and no treatment).  
These investigators found that 31percent of the women from the 
MCLNO experienced delays in diagnosis that were greater than 60 days 
from clinical presentation with initial abnormality to diagnosis of breast 
cancer.  African American race, stage, type of abnormality at 
presentation, and tumor size were all significantly associated with 
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diagnostic delays. In addition, these investigators found that African 
American race, early-stage classification, abnormality found by 
mammogram and decreasing tumor size were all risk factors for 
diagnostic delays. Although not statistically significant, Caucasian 
women experienced more treatment delays compared to African 
American women (20.9% versus 11.3%, p=.089). Finally, women 
experiencing treatment delays were significantly older than their 
counterparts not experiencing delays. For every 10 year increase in age, 
the odds of experiencing a treatment delay increased 1.6 times (OR 95% 
CI=1.12-2.26). A significant limitation of this study was the small sample 
size, which the authors acknowledge, along with the use of retrospective 
data from a single institution. 
 Gorin, Heck, Cheng and Smith (2006) examined delays in breast 
cancer diagnosis and treatment by racial/ethnic group. The purpose of 
the study was to describe time delays in the initial diagnosis and 
treatment of primary breast cancer of insured women using Medicare 
recipients. Racial/ethnic groups were compared in their diagnostic, 
treatment, and clinical delay (N=49,865). The women who had billing 
claims for diagnosis delay, treatment delay, and combined clinical delay 
(combined diagnostic and treatment delay) were identified through the 
SEER program. The racial groups were comprised of Caucasian 
(n=43,627) African American (n=2982) Asian/Pacific Islander (n=1617) 
and Hispanic (n=1296) women diagnosed with breast cancer within the 
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previous five years. Statistical analysis was conducted using chi-square 
and computer program PROC GLIMMIX to compare and analyze the 
associations between ethnic/racial groups. These investigators found 
African American women experienced the most diagnostic delay (median 
29 days) with 22 percent experiencing delays for more than 2 months as 
compared to Caucasian women (18.3%) and Hispanic and Asian women 
(18%). In addition, African American women experienced the greatest 
amount of treatment delay (30.1%) as compared to Caucasian women 
(18.7%); Hispanic women (19.7%); and Asian/Pacific Islander women 
(21.7%). Eleven percent of African American women experienced 
combined clinical delay (2 month diagnosis delay and 1 month treatment 
delay) as compared to Caucasian (5.1%), Hispanic (6.5%), and 
Asian/Pacific Islander women (6.5%). In addition, this research found 
that while access to physicians were greater among African, Hispanic, 
and Asian/Pacific Islander women than among Caucasian women, more 
visits led to significantly increased diagnostic and combined clinical 
delay. These findings suggest that increased visits to healthcare 
providers were not sufficient enough to ensure timely use of diagnostic 
and treatment services.  
 Martinez et al. (2010) examined the use of radiation therapy in 
African American, Caucasian, Asian, and Hispanic women with advanced 
breast cancer.  The SEER database was used to identify Caucasian, 
black, Hispanic and Asian patients with invasive breast cancer. The 
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sample included women who had stage III ( 10 metastatic lymph nodes) 
breast cancer (n=12,653). The majority of the patients were Caucasian 
(72%); Hispanic (10.4%); African American (10.3%); and Asian (7.3%). 
The patients were divided according to whether radiation therapy was 
given. Differences were compared among racial groups using analysis of 
variance for continuous variables ad chi-square testing for categorical 
variables, proportions, and univariate logistic regression.  
These investigators found disparities existed for African American 
women as compared to the other racial groups. African American women 
had the largest mean tumor size and were less likely to have radiation. 
Radiation therapy is a key component in the management of patients 
with advanced breast cancer. It is indicated for all patients undergoing 
breast conservation. Postmastectomy radiation therapy is the current 
standard for breast cancers with 4 axially lymph node metastases. 
Adherence to these guidelines is a marker for quality cancer care. These 
investigators identified that both African American and Hispanic women 
(45.8% and 48.6% respectively) were less likely to receive radiation 
therapy than Caucasian women (51.6%). Moreover, regardless of the 
racial/ethnic disparities, noted rates of radiation therapy were low for all 
populations with a range of 46 to 54 percent, but the reasons for this 
were unknown. However, researchers posited that clinicians were taking 
a nihilistic approach to patients and perhaps were assuming that they 
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had occult systemic disease and did not consider the need for radiation 
therapy (Martinez et al., 2010). 
Critique. The above-mentioned research highlights disparities 
regarding diagnostic delays, age, and treatment. It highlights the 
importance of having the right treatment for the right type of breast 
cancer. These studies show a gap in the standards of treatment offered 
and that national treatment standards are an area for exploration. A 
couple of limitations that were noted were hormonal therapies were 
omitted in research by Gorin et al. (2006) and the specific reasons for the 
diagnostic delays are unknown for Williams et al. (2010). Also the issue 
of having access to diagnostic equipment is an important factor that 
needs to be explored further. The impact of treatment delays on age need 
further exploration. Finally, an exploration of the specific type of 
treatments offered to African American women when making their 
decisions is needed.   
Breast Cancer Disparities and Health Insurance  
 Komenaka et al. (2010) researched race and breast cancer 
outcomes in the underinsured population. A retrospective review of 
medical records were used to draw comparisons between non-Hispanic 
Caucasian (n=259) and African American women (n=315) who were 
identified as being diagnosed with breast cancer utilizing a Cox 
proportional hazards regression analysis. Specific criteria for being 
considered underinsured were: a) if they did not have commercial 
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insurance or HMO coverage and b) if they had Medicare and Medicaid 
due to the limitations of coverage in these types of programs. The 
investigators found African American women were more likely to be 
unemployed, retired or disabled. African American women were more 
likely to have Medicaid or no insurance than non-Hispanic Caucasian 
women. African American women presented with more advanced clinical 
stage disease 52 percent had stage II-IV as compared to the non-
Hispanic Caucasian women who had 41percent with these stages. 
Furthermore, African American women had a higher number of 
recurrence with distant metastases (70%) than their non-Hispanic 
Caucasian counterparts (49%).  These investigators also found that late 
stage disease at diagnosis was the number one factor in the disparities in 
mortality between the two groups with proportionately more African 
American than non-Hispanic Caucasian women dying of breast cancer 
(18.6% vs 12.2%).  
 Similar research by DeSantis, Jemal and Ward (2010) compared 
African American women and Caucasian women diagnosed with invasive 
breast cancer stage III-IV. The researchers selected African American 
(n=24,483) and Caucasian women (n=169,486) ages 20-99 from the 
National Cancer Database. Logistic regression models were used to 
assess the associations between demographic characteristics and breast 
cancer prognostic factors. They compared age, race, insurance, 
education, stage of breast cancer, tumor size, and lymph node 
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involvement. They found that African American women were more likely 
to be younger, uninsured and live in zip codes where a large percentage 
of the population lacked a high school diploma. The breast tumors in the 
African American women were more likely to be larger, less differentiated, 
hormone receptor positive and have positive lymph nodes and 
metastasis. They found that adjustment for insurance and area-level 
educational attainment explained a substantial proportion of the African 
American –Caucasian difference in metastasis, tumor size and lymph 
node status. Being uninsured was strongly associated with not having 
regular mammography screenings which resulted in the diagnosis of 
more advanced tumors (DeSantis et al., 2010).  
Critique. Research in this area provides strong evidence for 
increased tumor size, late diagnosis, and the potential for metastasis in 
African American women, over other ethnic groups, being directly related 
to mortality. Specifically, having insurance did not mediate differences 
between African American women and other ethnic groups. These 
investigators also linked zip codes and clustering of breast cancer 
patients in a geographical location to being underinsured. Limitations in 
the above studies are small sample sizes, the use of one institution, 
retrospective data (Komenaka et al., 2010) and not considering unknown 
comorbidities that affect breast cancer prognosis  (DeSantis et al., 2010). 
The findings highlight exploration of being underinsured versus insured 
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and decision making, specifically, how personal finances affect treatment 
decision making. 
Patient-Physician Communication 
 Patient physician communication is important to the process of 
decision making by African American women. The literature in this area 
highlights the disparity in communication between African American 
women and their healthcare providers (Royak-Schaler et al., 2008). 
Williams et al. (2008) explored communication and decision making with 
health care providers in African Americans living with cancer and their 
families. They utilized focus groups to identify and explore cultural 
perceptions, expectations, and desires as they related to quality of life 
(QOL). Thirty-three African American women participated with 21 of the 
other focus group members being caregivers of a family member with 
cancer.  
The investigators utilized grounded theory and found the following 
themes: 1) Effective communication where the participants stressed that 
a fundamental part of effective communication was the establishing of a 
relationship with which the physician and other healthcare providers 
sought to “know and understand” the patient and family as individuals. 
In addition, in knowing the individual patient, the physician/healthcare 
provider should communicate with them based on that knowledge. 
Lastly, the “knowing” of the patient was also the foundation for effective 
decision making. 2) Decision making with one of themes being having a 
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sense of control. The participants felt that the physicians/healthcare 
provider role was to clearly outline available options and then to respect 
the decision making ability and choices of the patient and their family. 
Secondly, not all patients have the capacity to be self-advocates and 
participants expressed concern for vulnerable populations. Lastly, 
individuals who were older, poorer, and had low levels of formal 
education were at particular risk. The participants felt it very important 
that vulnerable populations “need to know that they have a choice” 
(Williams et al., p.1223). 
 Maly et al. (2008) studied the differences of physician 
communication and patient empowerment in older women with breast 
cancer. A cross sectional sample of Latina (n=99), African American 
(n=66), and Caucasian women (n=92) over the age of 55 and who were 
recently diagnosed with stage I or higher breast cancer were recruited.  
The participants were interviewed either by telephone or in-person. In 
addition, the participants completed a supplemental self-administered 
questionnaire regarding physician communication. The researchers 
utilized a confirmatory factor analysis to assess three hypotheses: 1) 
There would be racial/ethnic disparities in older women’s QOL and 
breast cancer treatment; 2) Patient empowerment through physician 
communication, as reported by patients would predict better QOL and 
receipt of breast conserving surgery (BCS) and: 3) Relationships among 
race/ethnicity and the outcomes of QOL and BCS would be mediated by 
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physician and system level factors (physician communication and 
perceived racism) and patient cognitive factors (self-efficacy, knowledge, 
and coping).  
Inspection of the results showed African American women reported 
good QOL whereas Latinas reported worse QOL. African American and 
Latina women received BCS less often compared with Caucasians. 
Greater patient perception of interactive information giving and shared 
treatment decision-making by physicians correlated with increased QOL 
and receipt of BCS. Compared with Caucasians, African Americans 
expressed substantial mistrust of the health care system and Latina 
reported somewhat less mistrust. In addition medical mistrust also 
predicted decreased feelings of self-efficacy in interacting with 
physicians, thus reducing both QOL and the likelihood of receiving BCS. 
African American race was significantly and negatively (r =-.14, p<.001) 
associated with physician emotional support and breast cancer 
knowledge. Latina ethnicity was significantly and negatively (r = -.32, 
p<.001) related to both breast conserving surgery and quality of life. 
Greater patient perception of interactive information giving and shared 
treatment decision making by physicians correlated with increased 
quality of life.  
Critique. The above research supports the need for more 
exploration into communication patterns of physicians and the need for 
information gathering of women with breast cancer. The research also 
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highlights issues with physician trust, communication, and quality of life 
which has implications for follow up and survivorship. Both of these 
studies specifically addressed decision making and information needs. 
The use of grounded theory to examine communication was noted in the 
Williams et al. (2008) study. Limitations noted for both studies were the 
small sample sizes and use of nonrandom sample and potential bias 
(Williams et al., 2008) and variance in the definitions of effective 
communication. This research lends insight into the exploration of the 
specific informational needs of African American women at the point of 
diagnosed with breast cancer. 
African American Women and the Decision Making Process 
 Decision making is a multifaceted phenomenon (Broadstock & 
Michie, 2000). A review of the literature reveals decision making theories 
and frameworks from medical to organizational disciplines. Yet, grasping 
what decision making is for African American women who are facing a 
challenging illness is complex. There are many decisions that any woman 
would need to make once diagnosed with a life threatening disease. Some 
of the seminal work by Hack et al. (1994) who examined decisional 
control and illness information and Biloudeau and Denger (1996) and 
Denger et al. (1997) who examined decision roles, preferences, and 
involvement for Caucasian women laid the ground work for other 
research into decision making and breast cancer illness.  The following 
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literature will describe research regarding decision making and breast 
cancer.  
Decisional Roles and Preferences 
 Katz et al. (2005) examined the relationship between patient 
involvement in decision making and the type of surgical treatment 
chosen. Women were chosen by random sampling with the Surveillance, 
Epidemiology and End Results (SEER) database, who had invasive breast 
cancer, stages 0-II and were classified has being post-surgical. Seventy-
seven percent of the women eligible for the study completed a written 
survey (n=2,382). If the written survey was not returned, the remaining 
participants were called and completed an abbreviated telephone survey 
(n=1844). The authors developed instruments to specifically measure 
independent variables of patient involvement in surgical decision making 
and clinical factors (i.e. cancer stage, medical comorbidities, and clinical 
contradictions to BCS or mastectomy) and utilized logistic regression to 
determine the type of surgical treatment received. Study results showed 
racial differences between numbers of surgeons seen, number of office 
visits, timing of decision, and surgical recommendation. African 
American women visited more surgeons, had more visits before surgery 
and were less likely to have made the surgical decision during the first 
consultation. In addition, African American women reported receiving 
less information about breast conserving surgery. Surgeon decision 
control was strongly associated with receipt of breast conserving surgery 
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for Caucasian women; this association was less evident for African 
American women. In fact, African American women were more likely to 
have received mastectomy compared with other ethnic groups when the 
decision was perceived to have been made by the surgeon. 
 Hawley et al. (2009) evaluated the association between patient 
decision involvement and surgery received in an ethnically diverse 
population of Latina, African American and Caucasian patients. 
Secondly, they evaluated patients’ attitudes about surgery and the role of 
family and friends in surgical treatment choices. Women were recruited 
using a SEER registry by random sampling with a sample size of 
(n=1651): Latina (n=395), African American (n=448) and Caucasian 
patients (n=808). This study was designed to stratify race with women 
who had early stage breast cancer 0-II. Written survey instrumentation 
was used (96.5%) with follow up telephone surveying (3.5%) for those 
who did not return the written survey. The authors used the framework 
of health care utilization. The patient survey assessing the initial surgery 
the patient received was based on a pilot study utilizing this framework.  
Patient involvement was measured using the control preferences scale 
developed by Denger et al. (1997). The control preference scale asks 
respondents to rate their actual involvement in medical decision on a 5-
point scale (Hawley et al.). Latina patients were further categorized by 
low-acculturation and high-acculturation by utilizing the short 
acculturation scale by Hispanics developed by Marin et al. (1987). Patient 
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attitudes regarding surgery were assessed by asking the patient to 
indicate the importance of issues related to cancer recurrences, 
radiation, and body image. ANOVA was used to evaluate racial and 
ethnic differences in age at diagnosis. Logistic regression models were 
constructed to examine the odds of having a mastectomy as the initial 
surgical treatment.  
The results showed the majority of women reported shared surgical 
treatment decision making. All women reported concerns that 
recurrences were important in their treatment decision making. However, 
African American women indicated that this issue was quite or very 
important more often than the other groups. In addition, African 
American women and high-acculturated Latina patients reported that 
body image concerns were quite or very important in their treatment 
decisions. Most women reported having a family member or friend 
present during surgical consultation. However, African American women 
were least likely to report having been accompanied. Moreover, African 
American women were the least likely to indicate that their spouse was 
very important in decision making. In regards to decision involvement 
and initial mastectomy, most of the women who initially received 
mastectomies were greatest among women who reported a patient-based 
decision compared with those who reported a shared or surgeon-based 
decision. Women who reported that concerns about recurrence and 
radiation were very important in their decision making received 
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mastectomy significantly more often than women for whom concerns 
about these issues were of little importance. Conversely, those who were 
quite or very concerned about body image were less likely to receive 
initial mastectomy compared with those who were not very or moderately 
concerned.  
 Critique. Findings from these studies are important because they 
involved three key factors; patient perception, patient involvement, and 
treatment choices in surgical decisions. They provide information on 
various ethnic groups (African American, Caucasian, and Latina) and 
how these women preferred to participate in treatment decision making. 
These studies provided information on the specific types of decision 
making and informational needs of women with early stage breast 
cancer. In addition, Hawley et al. (2009) specifically studied how women 
rated their decision making, the role of their significant others in their 
decision making, and support in their surgery consultations. A strength 
of the Katz (2005) study was that it illustrated how physicians presented 
the information to their breast cancer patients. Some physicians only 
presented one option, while others were careful to lay out all of the 
alternatives. A strength of these studies is the use of the SEER registries 
because they are population-based registries that would potentially yield 
a sample that is generally representative of the population in that 
geographical area. Another strength of these studies is that they began to 
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tease out what other factors influence patient involvement and patient 
attitudes and the role of others in the patient’s decision making process. 
Limitations of these studies include not addressing the time frame 
involved in decision making nor evaluating the physician’s involvement 
in decision making. Lastly, neither study examined women with 
advanced stage breast cancer.  
Perceptions and Experiences of Treatment Decision Making  
  Wenzel and Shaha (2008) explored women’s perceptions of and 
experiences with breast cancer treatment decision making in Managed 
Care Organizations (MCO) to ascertain if any limitations were imposed on 
treatment options. Utilizing phenomenology, women (Caucasian n=9; 
African American n=4; and Asian Pacifica Islander, n=1) were interviewed 
who were enrolled in a MCO from their initial treatment decisions (6-8 
weeks) through any decisions made regarding chemotherapy and/or 
radiation (1 year or longer). The results showed how participants 
reported preferring to defer treatment decisions to their provider and 
relied on advice and recommendations from family or friends, especially 
from previous cancer survivors. In addition, women related that some 
decisions were dictated by the cost of premiums and provider choice. 
These women wanted the MCO to offer more choices in their treatment 
facilities and retain trusted cancer providers. Some women expressed 
concerns about the difficulties of being accepted by another health plan 
should their spouse change jobs. 
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Halkett et al. (2007) sought to understand the phenomenon of how 
women made decisions when diagnosed with early stage breast cancer. 
This study was different from other decision making studies, in that the 
investigators explored the experiences of making these decisions, rather 
than the decisions themselves. The authors interview 18 South 
Australian women who had completed treatment, and were guided by a 
hermeneutic phenomenological design. The investigators found that 
during their experience with early breast cancer, women found they 
needed to make many decisions, including: Who they would talk to; 
which provider or providers they would consult; what treatment they 
would receive; how they would communicate with healthcare 
professionals; how active they would be in their treatment choices; 
whether to seek a second opinion; how to react to their diagnosis; what 
meaning they would allocate to breast cancer; and how breast cancer 
would change their lives. The themes identified where: Being challenged 
where the experience of making decisions began when the women 
suspected they had cancer and decided to go for a mammogram; Getting 
ready, when the women received the diagnosis, they attempted to get 
into a state of readiness; Surviving, where the experiences of making 
decisions was characterized by the need to survive; Sharing the 
challenge, where the women did not experience the challenge of breast 
cancer and making their decisions alone; and Interrogating the future 
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where the phenomenon of making decisions was a continuous 
experiences because of the ongoing effect on their lives. 
Lally (2009) explored the pretreatment thoughts and behaviors of 
women newly diagnosed with breast cancer regarding their surgical 
treatment decision making experiences. The investigator utilized a 
grounded theory methodology. Lally interviewed 18 women with stage 0-
II breast cancer who had either: 1) Undergone surgical consultation with 
one of four general surgeons or a surgical oncologist; or 2) Had been 
presented with surgical options but had not undergone surgical 
treatment. Inspection of the results showed the pretreatment period was 
characterized by the following themes: a) Information processing where 
overall the women felt that information about breast cancer was 
important, plentiful and readily available and that their needs were met; 
b) Contemplating options, this involved making the choice between 
lumpectomy or mastectomy with or without breast reconstructions; and 
c) Interacting with others, with the women experiencing multiple 
interactions with healthcare providers and family and friends who 
affected their decision making. In addition, the investigator found that 
women did not share their preferences with their surgeons and that 
surgeons did not make treatment recommendations. In fact, treatment 
options were contemplated and preferences formed often before the initial 
surgical consultation. 
43 
 
 
 
Critique. The above research demonstrates how important 
communication and timing are in the decision making process. 
Specifically, how allowing time for contemplation and the availability of 
choices are key factors in decision making. This research also highlighted 
how women demonstrated trust in their providers by utilizing a passive 
decision style. Most importantly, this research highlights how facilitating 
women’s decision making early in the process when they are making 
critical choices is key to their smooth transition from a health state to an 
illness state. A strength of this research was that it provided alternate 
descriptions for informed and shared decision makings, where informed 
decision making involved information gleaned from sources other than 
the physician. A limitation of the Halkett et al. (2007) study was that it 
did not look at who supported the women in their decision making. 
Another limitation noted was in the Wenzel and Shaha (2008) study 
where the specific stage of breast cancer nor the effects of cost 
containment on treatment decision making were assessed.  
Decision Making and Social Processes 
 Fowler (2006a) sought to describe the social process used by 
African American women in making decisions regarding mammography 
screening. Fowler used grounded theory methodology to interview 30 
African American women of diverse socioeconomic backgrounds. Results 
showed that the women’s decisions were associated with five social 
processes: 1) Acknowledging prior experiences with healthcare providers 
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and systems where assertiveness skills and prior positive experiences 
with healthcare providers accounted for prior success in navigating 
healthcare systems; 2) Reporting fears and fatalistic beliefs and related 
treatment, where participants pondered the negative effects of breast 
cancer but realized the benefits of adherence to breast health 
recommendations; 3) Valuing the opinions of significant others, where all 
participants identified with influential women in the media promoting 
empowerment for African American women; 4) Relying on religious beliefs 
and supports, where this group of women used the bible or religious 
scriptures metaphorically to affirm or reaffirm positive role-model images 
of strong and powerful women when confirming decision–making about 
mammography screening; and 5) Caregiving responsibilities of significant 
others, where caregiving was necessary for the protection and social 
interactions of future generations.   
Critique. This investigation was important because it linked 
culture and social ties to screening practices. Although, the investigator 
looked only at how mammography screening decision making was 
employed, some of the themes could be extracted for future exploration 
with women diagnosed with breast cancer. The strength of this 
investigation highlights how social support plays an important role in 
decision making with African American women. Another strength of this 
investigation is that it highlights the need of establishing credibility in 
the African American community. A limitation noted was the sample 
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consisted of religious women which views might differ from non-religious 
women.  
The Utility of the Cultural Capital Conceptual Model 
 Integrating Bourdieu’s theory with the culture aspects of African 
American women and breast cancer treatment decision making will aid 
in outlining cultural resources, the obtainment of these resources, and 
how these resources can help African American women navigate the 
health care system. This theoretical perspective was important because it 
helped to frame an explanation for the differences in why African 
American women are dying more so than any other ethnic group.  
The basic tenets of this theory are how one utilizes existing 
cultural resources (cultural norms and values, social, and economic 
supports), how to profit from these resources, and how to accumulate 
more resources. Most importantly, these tenets provide a structured 
argument for functioning in the social world (Bourdieu, 1986). So for 
African American women to be able to take a cultural inventory and 
assess what cultural resources they do and do not possess, gives them 
the opportunity to fully utilize their resources or improve upon any 
deficiencies. This is a problem based theory where action is required 
(Abel, 2008). So, where they see inequality they can take action or tap 
into their resources to change their circumstance. One way Bourdieu 
elaborates on for changing and gaining cultural resources is through 
education (Bourdieu, 1986). By obtaining more knowledge (e.g. college 
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education) a person can improve upon their cultural, social, and 
economic resources. This in turn, provides people with more assets in 
which to navigate their world. This is extremely important for African 
American women who face health care disparities. By tapping into one’s 
cultural capital, a woman can begin to educate herself, improve upon her 
linguistic skills, be aware of her social position field, and feel more 
empowered to be a participant in her healthcare. 
Chapter Summary 
How African American women with advanced breast cancer make 
treatment decisions remains unknown. This literature review illustrates 
many examples of health disparities and known areas of decision making 
that attempt to ferret out these processes. The disparities presented in 
this literature review show how African American have limited access to 
care when it comes to delays in diagnosis and treatment. In addition, 
most of the studies did not assess if the women being studied had 
regular healthcare providers. Furthermore, geographically the lack of 
access to care is focused on rural areas. However, the limits in access to 
care in urban areas is not understood for this population and is an area 
for exploration.  
This literature review details specific disparities with radiation 
treatment as an option. Therefore specific treatment options need to be 
explored with this population. Also, this literature review revealed 
another major area of disparities involving patient-healthcare provider 
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communication and the barriers that exist within this relationship. What 
it did not reveal was a definition for effective communication and the 
level of trust that is needed for women making treatment decisions. 
Finally, there was a specific conceptual gap noted because there has 
been no research that utilized Bourdieu’s cultural capital theory with 
decision making in African American women diagnosed with advanced 
breast cancer. This theory has the potential to provide a cultural 
framework for understanding the decisional needs of African American 
women. 
There were a few studies that specifically focus on breast cancer 
and decision making. However, there was several methodological gaps 
noted with these studies that are outlined as follows:  
1) While the sampling of these studies made attempts at diversity, 
the sampling focused on women with early stage breast cancer and the 
sampling numbers for African American women were usually small with 
the majority number of women being Caucasian;  
2) There was limited information on cultural ties and social norm 
processes for women with advanced cancer; 
3) The literature review highlighted significant financial barriers for 
women getting treatment for breast cancer, however, barriers for women 
with advanced breast cancer remain unknown;  
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4) Specific measurements of who supported the women and their 
level of involved was alluded to (Katz, 2005; Hawley et al., 2009) but 
needs further exploration for women with advanced breast cancer;  
5) There was limited information regarding timing of decisions in 
the abovementioned research. Yet, the pressure of timing in decision 
making was a theme found in the pilot study by Sims (2009);  
6) The impact of patient-physician communication on decision 
making is well documented. However, the impact of this relationship in 
treatment decision making needs to be explored; 
7) Many of the studies were retrospective reviews or chart studies. 
However, there was a caveat in the study by Lally (2011) which included 
a prospective review utilizing grounded theory and this type of study 
would be optimal for women with advanced breast cancer to capture 
decision making over time; and lastly, 
8) There were no studies that examined the treatment decision 
making process from diagnosis through follow-up.  
This literature reveals the need to study the concept of how African 
American women with advanced breast cancer make their treatment 
decisions in the context of their everyday lives. This study will focus on 
the identified knowledge gaps through an investigation using grounded 
theory methodology to capture the processes utilized by this group of 
women. To this end, a substantive theory will be generated regarding 
treatment decision making.
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Chapter Three 
Methods 
Design 
 Being diagnosed with advanced breast cancer involves complex 
decisions that require a simultaneous need for disease knowledge 
(Broadstock & Michie, 2000; Fagerlin et al., 2006). A grounded theory 
methodology allowed an exploration of the decision making processes of 
African American women as they address their disease trajectory with 
various treatment modalities. In this chapter an overview of grounded 
theory, protections of human rights, instrumentation, data collection 
procedures, analysis, and establishing rigor are provided.  
Overview of Grounded Theory 
 The grounded theory method was developed by Glaser and Strauss 
(1967).  Grounded theory methods involves an inductive process using a 
constant comparative method. The goal of this method is to develop a 
theory that describes the process of social interactions that characterize 
a particular experience (Ayres, 2007). This method identifies a basic 
social process that emerges over time as data are coded through several 
levels of abstraction. It involves data collection with the generation of 
hypotheses and categories through open, selective, and theoretical 
coding, and theoretical memos (Glaser, 1978).  Glaser explains “this 
process generates theory that fits the real world, works in prediction and 
explanations, is relevant to the people concerned and is readily 
modifiable” (p.142). Most importantly, grounded theory provides nursing 
50 
 
 
 
with a viable means of generating theory grounded in the realities of 
everyday clinical practice (Elliott & Lazenbatt, 2005). 
Pilot Study Findings 
 A pilot study was conducted by the investigator utilizing grounded 
theory to explore informed decision making in African American women 
(N =6) diagnosed with breast cancer to answer these questions: 
1. How do African American women describe their decision making about 
detection screening practices, diagnosis and treatment of their breast 
cancer? 2.  What information is needed to facilitate African American 
women’s decision making? Sample characteristics were as follows: The 
average age at diagnosis was 53 years. The initial diagnosis of breast 
cancer for two of the women has been within the past year and they are 
currently undergoing chemotherapy and/or radiation. The initial 
diagnosis for the remaining women ranged from 2-6 years.  There was 
one woman who has had breast cancer twice in the same breast, with 
three years between reoccurrences. Four of the women are employed and 
two are retired. 
  Preliminary analysis utilized a structured interview guide to 
facilitate the inquiry and found several themes: levels of decision making, 
decision making styles, decisional autonomy, factors that assist with 
decision making, and informal decisional processes.  This pilot study 
emphasized the complexity of decision making including the varying 
sources of information the women had to process and sort through, the 
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navigation of the medical system with coordinating two or more 
physicians and treatment options, and time, where decisions needed to 
be made rapidly, as an essential factors. Most importantly, this pilot 
study demonstrated that variations in stage and treatment decisions 
were an important factor. Treatment decision making in woman with 
stage I versus a stage III breast cancer were vastly different. 
Analysis 
Undertaking the pilot study assisted the investigator with 
understanding cultural issues in interviewing techniques and the need to 
establish credibility with participants effectively before delving into 
sensitive information. In addition, information gleaned from this pilot 
study showed that this inquiry was too broad in its scope and needed to 
be more focused on women with advanced breast cancer for the 
dissertation study. Lastly, the investigator learned how to apply to the 
Institutional Review Board (IRB) for human protection and organize 
research documents and data.  
Protection of Human Subjects 
 Approval to conduct this study was granted by the IRB from the 
University of Wisconsin-Milwaukee (UWM) and Swedish American 
Hospital Treatment Center, Rockford, Illinois (see Appendix A). Each 
participant signed a consent form (see Appendix B) and agreed to be 
audio-taped. The investigator explained to each participant how their 
anonymity would be ensured. Participants were allowed to pick a 
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pseudonym and the investigator referred to them by this pseudonym 
throughout the audio-taped interview. Other procedures to ensure 
anonymity included keeping audio files and transcriptions on a personal 
password protected computer, destroying the file that links the 
participants name with their pseudonym, and erasing all digital and 
audio files at completion of the study. 
Sample 
 This study included a purposive sample of 12 African American 
women diagnosed with stage II to IV breast cancer living in or near 
Rockford, Illinois.  Participants were recruited from a large regional 
cancer treatment center. African American women were recruited who 
met the following inclusion criteria: 1) Over the age of 30, 2) Able to 
understand, speak, and write English, 3) Had no cognitive impairments 
(Alzheimers, Dementia, etc.), 4) Diagnosed with stage II, III, or IV breast 
cancer, 5) Had an initial diagnosis of breast cancer within the past 4 
years, and 6) Were currently or had previous been in treatment for breast 
cancer. Employing theoretical sampling, an initial sample of nine women 
were interviewed, and sampling continued beyond data saturation to 
interview three additional women to ensure complete data saturation.  
Setting 
The participants were recruited from a large regional cancer 
treatment center. This treatment center serves a large multi-county area 
and offers several treatment therapies along with clinical trials. A staff 
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research nurse coordinated the recruitment based on the inclusion 
criteria provided. This coordinator handed out flyers (see Appendix C) 
and spoke with participants who expressed interest in the study. These 
participants were asked to provide their contact information. Then, an 
email was sent to the investigator with the participants contact 
information and an interview was set up at a convenient time. All 12 
interviews were conducted in the participants’ homes.   
Instrumentation 
 A semi-structured interview guide was developed to interview the 
research participants (see Appendix D).  An interview guide matrix was 
developed to ensure all the research questions were addressed (see 
Appendix E). In addition, to capture any clustering of breast cancer by 
geographical area, a demographic information sheet was developed (see 
Appendix F).  
Procedures 
   All of the interviews were digitally recorded and transcribed 
verbatim by a transcriptionist. Each interview lasted approximately 60 to 
90 minutes. After each interview field notes were written to include 
recording the geographical location, neighborhood and home setting, 
reflections about the participant and/or interview process. The 
demographic sheet was filled out by each participant after the interview 
was complete and the audio taped stopped. This allowed participants to 
ask questions clarifying information on the demographic form without 
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providing identifying information. At the end of the interview the 
participants were given a $20.00 visa gift card in appreciation for their 
participation. The possibility of a second interview was built into the 
consent form and was explained to the participants as either being either 
another in-person visit or telephone call. Nine of the participants were 
called to clarify information and/or reflect on themes to see if this 
captured their experiences. 
Analysis 
  Open coding was initiated immediately once the interview 
transcription was complete. The constant comparative process was 
initiated with the first interview and continued throughout the analytic 
process (Glaser, 1992). The coding was organized with N-Vivo 10. This 
iterative process continued until theoretical saturation was achieved 
(Glaser, 1978). Theoretical memos were generated, and data reduction 
(selective coding) was performed looking at the frequency of the codes to 
decide which codes were representative of the emerging theory (Glaser, 
1978; 1992). Beyond selective coding, theoretical coding resulted in the 
development of core categories from which the basic social process of the 
grounded theory emerged (Glaser, 1978; 1992). Theoretical coding 
involved utilizing modeling to visualize and show relationships embedded 
in the data (Glaser, 1978). As data analysis progressed the semi-
structure interview guide was revised to capture the emerging theory (see 
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Appendix G). Approval to use the revised interview guide was obtained 
through an IRB amendment. 
Establishing Rigor 
 Establishing that the findings of a qualitative research study are 
rigorous is critical for dissemination of the research and advancement of 
sound science. One way to guarantee rigor is to include procedures that 
establish the credibility of the analysis throughout the research process. 
Glaser and Strauss (1967) related four properties in establishing 
trustworthiness and credibility: fitness- where the categories within the 
theory must directly related to the data; work- where the theory should 
have an explanatory power and be able to interpret what is taking place 
within the context of the theory; relevance-where the theory is relevant 
because the researcher allows the core problems and processes to 
emerge from the data rather than attempting to impose a preconceived 
theory on to the area of study; modifiability-where given that the social or 
clinical world is constantly changing, the theory must be adaptable and 
modifiable.  
 Rogers and Cowles (1993) discuss the research audit trail and how 
important documentation is to any rigorous qualitative study.  It is 
necessary to maintain accurate and comprehensive notes related to the 
contextual background of data, the impetus and rational for all 
methodological decisions, identifying the evolution of the findings and 
the researchers’ particular orientation to the data are essential to ensure 
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rigor (Rogers & Cowles).  Finally, Lincoln and Guba (1985) outline four 
criteria for trustworthiness for qualitative research: credibility, 
transferability, dependability and confirmability. These criteria were used 
to establish rigor in this study. 
Credibility 
 Credibility refers to confidence in the truth of the data and their 
interpretations (Lincoln & Guba, 1985; Polit & Beck, 2008).  Lincoln and 
Guba (1985) suggest five activities that make more credible findings. 
These include prolonged engagement, observation and triangulation 
(sources, methods and investigators), peer debriefing, negative case 
analysis, referential adequacy, and member checks. Credibility in this 
study was established with periodic meetings with the major professor to 
discuss emerging concepts, issues, and concerns as well as provide 
updates to recruitment, data collection, and analysis.  
Dependability 
 Dependability refers to the research process by examining the 
methodological and analytic decision trails created by the investigators 
during the course of the study. Systematically documenting the 
rationale, outcome, and evaluation of all actions related to data 
collection, sampling, analysis, and dissemination (Hall & Stevens, 1991). 
Dependability is how stable and reliable is the data over time and 
conditions (Polit & Beck, 2008). Dependability can be established by 
overlap methods, stepwise replication, and inquiry audit (Lincoln, & 
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Guba, 1985). Dependability in this study was established by using the 
constant comparative method, keeping theoretical memos, and coding 
reports that could be exported from N-Vivo to a spreadsheet to trace the 
investigator’s decisions throughout the analysis. 
Confirmability 
 Confirmability refers to objectivity and the potential for congruence 
between two or more independent people about the data’s accuracy (Polit 
& Beck, 2008). Essentially, this process establishes that the data 
represents the information the participants provided. Confirmability is 
established by an audit trail (Lincoln & Guba, 1985). This investigator 
maintained an audit trail throughout data analysis. Detailed field notes 
and observations were kept along with theoretical memos. A doctorally 
prepared nurse familiar with qualitative approaches was utilized to 
perform an audit trail. All study data were submitted to the auditor 
including: Transcripts, field notes, theoretical memos, open and selective 
coding reports, along with theoretical models (see Appendix H for the 
auditor’s conclusions). 
Transferability 
 Transferability refers to how generalizable and applicable are the 
findings to other settings or groups (Polit & Beck, 2008). It is the 
responsibility of the researcher to provide “a thick description to enable 
someone interested in making a transfer to reach a conclusion about 
whether transfer can be a possibility” (Lincoln & Guba, 1985, p.315). In 
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addition, Lincoln and Guba point out “that it is the naturalist 
responsibility to provide the data base that makes transferability 
judgments possible” (p.316). Transferability occurred by providing a thick 
description of the substantive theory from use of the constant 
comparative methods, theoretical memoing, and audit trail. The reader of 
the grounded theory evaluates transferability. 
Chapter Summary 
 This chapter outlined the grounded theory methodology and study 
processes that were utilized to conduct this research. Sampling, data 
collection, management, and procedures, along with the protection of 
human rights were described. Finally, the procedures used to establish 
rigor were provided.  
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Chapter Four 
Results 
Chapter Four presents the results obtained from interviews of 12 
African American women diagnosed with advanced breast cancer. The 
purpose of this study was to generate a substantive theory of the 
treatment decision making process of African American women who have 
been diagnosed with stage II to IV breast cancer. The research questions 
for this study were: 
1. How do African American women with advanced breast cancer 
describe their process of making decisions about treatment? 
 a. How do women participate in treatment decisions? 
b. How is a woman’s participation in their treatment decisions 
facilitated? 
c. How is a woman’s participation in their treatment decision 
hindered? 
d. How do women describe their patient-health care provider 
communication and interaction in relation to treatment decision 
making? 
e. What additional resources do they utilize in making their 
treatment decision? 
2. What factors of cultural capital do women utilize when making 
treatment decisions? 
 a. What social supports do women utilize when making treatment 
 decisions? 
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b. How do economic circumstances affect treatment decision 
making? 
c. How do important cultural values or beliefs influence women 
when  making treatment decisions? 
 d. How do cultural concerns influence their treatment decisions? 
The first section of this chapter will summarize the sample 
characteristics of the study group and provide an individual synopsis of 
each participant. The second section will provide the grounded theory of 
treatment decision making derived from the data. Finally, the last section 
will discuss how the grounded theory addresses each research question. 
Sample Characteristics 
 
 The inclusion criteria for the study were: 1) age 30 or older; 2) 
diagnosed with stage II-IV breast cancer in the past 4 years; 3) starting 
treatment, actually receiving treatment, or have been in treatment; 4) 
able to understand and speak English; 5) report no known cognitive 
impairments. A total of 12 participants were recruited for this study.  The 
participants’ range in age was 32 to 78 years (M=55 years, SD, 13.9). Five 
of the participants were married (45%); four were single (36%); and three 
were divorced (25%). The participants reported diverse household 
incomes with the majority of participants (78%) reporting less than 
$40,000.00 annually (see Table 2). The geographical areas where the 
participants lived were reported to assess any clustering of illness. The 
majority of the participants (58%) lived in urban areas toward the center 
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of town. The other 40 percent of participants lived in suburban areas. 
Five participants (41%) reported having Medicare; three (25%) reported 
Medicaid; three (25%) reported having both Medicare and Medicaid; and 
two participants (16%) reported having Blue Cross/Blue Shield 
Insurance. The participant’s educational levels varied with a majority of 
participants report having a high school diploma or some college 
education. Two of the participants report having college degrees (see 
Table 2).  
Table 2 
 
Participant Demographics 
 
Demographic Age 
(Range) 
Mean(SD) Number 
(% of sample) 
Total N=12 32-78 55(13.9)  
Educational Level    
<HS Diploma   2(16%) 
HS Diploma   4(33%) 
Some College   4(33%) 
College Degree   2(16%) 
Marital Status    
Single   4 (33%) 
Married   5 (41%) 
Divorced   3 (25%) 
Geographical area (zip code)    
61101   4 (33%) 
61102   3 (25%) 
61104   1 (8%) 
61108   1 (8%) 
61109   1 (8%) 
61111   1 (8%) 
61112   1 (8%) 
Type of Medical Coverage    
Medicare   5 (41%) 
Medicaid   3 (25%) 
Medicare and Medicaid   3 (25%) 
Commercial (Blue Cross/Blue Shield)   2 (16%) 
Annual Household Income    
<$20,000   4 (33%) 
$21,000-40,000   5 (41%) 
$41,000-60,000   1 (8%) 
$61,000-80,000   1 (8%) 
$ 81,000-100,000   1 (8%) 
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Seven of the participants were diagnosed between one to three 
years before the interview. With five of the participants reporting being 
diagnosed within the past 9 months (see Table 3). For treatment, 
participants reported a variety and combination of treatment 
experiences. Six participants (50%) reported receiving chemotherapy and 
radiation; four (33%) report receiving chemotherapy only; one participant 
(8%) reported receiving radiation only; two participants (16%) report 
receiving adjuvant hormone therapy; and three participants (25%) 
reported being in various clinical trials.     
Table 3 
  
Treatment Demographics 
 
Diagnosed Number (percent of 
sample) 
9 months ago 5 (41%) 
1 year ago -3 years 
ago 
7 (58%) 
  
Type of Treatments  
Chemotherapy 4 (33%) 
Radiation 1 (8%) 
Chemotherapy and 
Radiation 
6 (50%) 
Other (Hormone and 
Adjuvant) 
7 (58%) 
Clinical Trials 3 (25%) 
 
 
Participant Synopses 
 A synopsis of each participant’s interview was created to locate 
each participant within their everyday context. Each participant was 
assigned a number at the time she was recruited into study to protect 
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her identity. A pseudonym was chosen for each participant for the 
purpose of reporting these findings. 
Interview with Participant 01: “Diana” 
Diana is a 54 year old married woman who was diagnosed nine 
months ago and had a mastectomy for stage II breast cancer. She is 
married; living with her husband in a single family home. She has one 
adult stepdaughter and parents that are very supportive. She reported 
feeling that she was misdiagnosed. She was told she had stage one 
breast cancer by one physician. However, she was called back, by the 
same physician, to the office seven months later and told that she 
needed to start chemotherapy and radiation. She was concerned and 
sought out a second opinion with a new physician. Two months ago her 
new physician told her that she should have had chemotherapy and 
possible radiation within the first three months because of her tumor 
size. In fact, she should have been treated for a stage II diagnosis. 
However, her window of opportunity for treatment was lost.  She 
currently is taking Tamoxifen daily for five years. She works, has 
insurance, and reports not having any trouble paying for her medication. 
 Interview with Participant 02: “Teresa” 
Teresa is a 50 year old single woman who was diagnosed one year 
ago and had a lumpectomy for a stage III breast cancer. She lives in a 
single family home with her adult sons and boyfriend. She describes a 
supportive family consisting of her sons, sister, and boyfriend. Her sister 
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attends all of her physician appointments with her. Teresa appeared very 
uncomfortable in her surroundings during the interview. Her home was 
chaotic. The television volume was loud and there were a lot of young 
people running in and out of her home. She complained of excruciating 
pain in the breast where she had the lumpectomy that was unresolved 
with medication. She feels her physician is indifferent to her pain issues 
and does not respond to her when she tells him about how much her 
breast hurt.  Her treatment consisted of approximately one year of 
chemotherapy. She is currently taking Anastrozole daily for five years. 
She reports that she has Medicaid and does not have any money 
concerns, yet she thinks having Medicaid is the reason why she cannot 
get any treatment for her pain.   
Interview with Participant 03: “Anna” 
Anna is a 60 year old married woman who was diagnosed two 
years ago and had a lumpectomy for stage II breast cancer.  She lives 
with her husband in a single family home. She has two supportive adult 
daughters and a sister. Her sister comes every day to clean and cook for 
her. Anna also has Multiple Sclerosis (MS) and has mobility issues 
related to this disease. Her husband is there to support her navigating 
the steps in their home. She has strong spiritual beliefs and feels that 
her spirituality is a part of her treatment. She had chemotherapy and 
radiation for several months. She is currently taking Leuprolide daily for 
five years. She reports having no problems paying for her medication now 
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that she has Medicare. When she worked she had Blue Cross insurance. 
However, when she was diagnosed with breast cancer and could no 
longer work she had to pay for Consolidated Omnibus Budget 
Reconciliation Act (COBRA) to continue her insurance coverage. Due to 
the exorbitant cost she terminated her Blue Cross coverage. Her money 
concerns were prevalent at that time because she had to pay $3,000 per 
month for her MS medication. Because the chemotherapy put her MS in 
remission and she now has Medicare, she no longer has any money 
concerns regarding her medication.  
Interview with Participant 04: “Crystal” 
Crystal is a 34 year old single woman who was diagnosed nine 
months ago and had bilateral mastectomies for stage III breast cancer. 
Crystal lives with her three daughters in a duplex apartment complex. 
She has limited family who live in the nearby area. Her three young 
daughters, ages 8-16, are supportive in cleaning the house and cooking. 
However, they are unable to drive and do errands for her. Yet Crystal 
describes being independent and does not want the help of her extended 
family. Her grandmother and other family members come to visit from a 
large city two hours away, but Crystal feels smothered by their care and 
concern. She takes being a role model for her daughters very seriously. 
She believes in relying on self. She is enrolled in college and has high 
expectations for the future. She would rather struggle through any 
obstacles in her life than ask for help. She has a difficult time trusting 
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others. At one point her physician told her to quit college. She refused 
because she did not trust what the physicians told her about being 
around large groups of people when going through chemotherapy. She 
eventually was hospitalized with shingles for two months due to her 
compromised immune system. She had chemotherapy for six months 
before surgery and will be completing radiation. Crystal is an 
entrepreneur. She has a hair salon and babysitting service in her home 
and speaks freely about the other businesses she would like to start. She 
reports having Medicaid and no money concerns.   
Interview with Participant 05: “Lynn” 
Lynn is a 68 year old married woman who was diagnosed two years 
ago and had a mastectomy for stage III-IV breast cancer. She lives with 
her husband in a single family home. She speaks of the love and care her 
husband gives to her since being diagnosed. She has a supportive 
extended family that is involved in her care. Hanging in her living room is 
a framed poster that was signed by several family members. This poster 
was given to her after going through surgery and chemotherapy and is a 
symbol of love to her. She shared how she is the oldest living family 
member and therefore the matriarch of the family. She is the holder of all 
history, wisdom, and knowledge for the family and takes her family 
responsibility seriously. Lynn is able to speak about her cancer with 
humor and humility. She is spiritual and frames much of her 
experiences with information from the Bible. Even though she had eight 
67 
 
 
 
lymph nodes removed that were positive for cancer, she was told by her 
physician that she did not need chemotherapy or radiation. She is 
currently taking Tamoxifen for five years. She reports having Medicare 
and Medicaid and no problem paying for her medication. 
Interview with Participant 06: “Maya” 
Maya is a 69 year old divorced woman who was diagnosed one year 
ago and had a mastectomy for stage II breast cancer. She lives alone is a 
single family home. Her support system consisted of three adult sons 
along with four adult nieces and a sister who are all nurses. Her nieces 
and sister were all supportive of Maya by taking turns coming to town to 
accompany her to her treatments. Her sons were very supportive by 
taking her to church and shaving their heads when she lost her hair.  
Maya is fiercely independent. She talks about when she was married, 
how her husband did not like to travel, so she would travel with her 
young sons alone. She feels that waiting is unnecessary. If you want to 
do something or go somewhere, you should make a plan and follow it.  
She has an adult niece who is a breast cancer survivor and she is 
adamant about only following the advice her niece provides regarding 
treatment decisions. Her treatment consisted of chemotherapy and 
radiation once weekly for three months. She does not take any other 
medications for her cancer but has regular follow up visits with her 
physician. Maya currently works approximately four to six hours a day 
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driving a bus for disabled children. She reports having Medicare with no 
money concerns.       
Interview with Participant 07: “Maria” 
Maria is a 56 year old married woman who was diagnosed nine 
months ago and had a lumpectomy for a stage III breast cancer. She lives 
with her husband in a single family home.  She has an adult son and a 
cousin, who is a breast cancer survivor, who are supportive. Maria feels 
that she was misdiagnosed by her surgeon. She was told that she had 
stage one breast cancer, yet when she went to the oncologist, she read 
her report that documented she had stage III breast cancer. She found 
out about the different diagnosis after the surgeon told her a lumpectomy 
is best for a stage one breast cancer. She feels that she made an 
erroneous decision based on faulty information.  She also is extremely 
angry that she was told over the phone by the radiologist that she had 
breast cancer. At the time she was informed of her breast cancer she was 
told to contact a particular surgeon. However, this surgeon was not 
forthcoming with her about the removal of several lymph nodes nor the 
advanced stage of her breast cancer. She feels that she did not receive 
proper treatment because of her race and the fact that she did not have 
insurance. Her niece who survived breast cancer, played a pivotal role in 
helping her to navigate the healthcare system in finding an oncologist. 
Her treatment consisted of chemotherapy three times per week for six 
months and daily radiation for seven weeks. She is currently taking 
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Tamoxifen for five years. She has significant money concerns because 
she and her husband were laid off at the time of her diagnosis. Even 
though she has a bachelor’s degree in social work she is unable to work 
due to her diagnosis. However, she was able to get some financial help 
from other agencies.  Currently, she has Blue Cross insurance through 
her husband’s job and has applied for disability. She reports having 
money concerns because of her past medical bills.  
Interview with Participant 08: “Amy” 
Amy is a 32 year old single woman who was diagnosed two years 
ago and had a lumpectomy for stage III breast cancer. She lives in an 
apartment with her teenage daughter. She has a very large supportive 
family that consists of her sister, brother, and 13 aunts and uncles. 
Amy’s mother died in childbirth and her baby brother died one week 
later, both from rare heart diseases, when she was eight years old. She 
was raised by her grandmother and aunts and uncles. Her brother and 
sister supported her by coming over and cooking for her daughter and 
taking Amy to her treatments. They provided comfort by giving her 
massages after her chemotherapy. Her aunts would come over to pray for 
her and clean her house. Her daughter helped her mother as much as 
she could while learning to be self-sufficient by getting herself ready for 
school. Because of Amy’s age and advanced breast cancer she had to 
have chemotherapy for two years. Amy recalled the intense fatigue, 
where she would sleep for 24 hours. There were times when all she could 
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do was watch a movie with her daughter. She recounts her extreme fear 
of everything. She was afraid of the needles, MRI machines, ultrasound 
machines, the intravenous medications, etc. She just had no frame of 
reference for the events that were happening in her life. In addition to the 
two years of chemotherapy she had radiation daily for several months. 
She is currently taking Tamoxifen for five years. She reports having 
Medicaid and no money concerns. 
Interview with Participant 09: “Joy” 
  Joy is a 66 year old married woman who was diagnosed 3 years 
ago and had a mastectomy for stage III breast cancer. She lives with her 
husband in a single family home. She has three adult sons and one adult 
daughter who are supportive. Joy and her husband are pastors of 
churches for three different locations. They have a large church family 
that supports them yet they have many responsibilities due to their 
occupations. Joy is intensely spiritual and believes in a divine order 
predestined by God. After Joy was diagnosed with breast cancer her 
husband had a stroke. Therefore, she had to arrange for her treatments 
and a caretaker for her husband. She was told to have a lumpectomy for 
her breast cancer by one physician, however when she went for her 
second opinion she was told to have a mastectomy. She choose to have 
the lumpectomy because the first physician had a ‘machine’ in his office 
and she felt that made him more thorough. She felt that was what God 
wanted her to do. After having treatment she was told her cancer was not 
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responding and she would now need a mastectomy. While recovering 
from her mastectomy Joy became ill and had four major surgeries to 
correct several intestinal hernias and to remove her ovaries. She is 
currently going through chemotherapy for a second time.  
Joy reports having Medicare and outlines several financial 
concerns stemming from the co-payments required by Medicare. With 
having so many appointments and each requiring a co-payment she was 
unable to keep up with the payments. When she had insurance, most of 
her treatments were covered and the amounts she was required to pay 
were manageable. However, having Medicare as a primary payor source 
is problematic, because Medicare does not pay for a large portion of her 
treatments. She spoke about all of the Medicare rules and legalese as 
being hard to understand.  She currently has several bills in collection 
and this is worrisome to her. With her and her husband being sick, she 
feels a tremendous amount of pressure due the lack of money. 
Interview with Participant 10: “Celine” 
Celine is a 47 year old divorced woman who was diagnosed 16 
months ago and had bilateral mastectomies for stage III breast cancer. 
She lives in an upstairs apartment with her children, one adult daughter, 
a 18 year old daughter, a 12 year old daughter, a six year old son, and 
an infant grandson. Her oldest daughter supports her mother by running 
errands, cooking, and cleaning for the younger children. She also has a 
supportive brother and mother. Her mother supports her by taking care 
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of her younger children when she is ill. Celine describes a toxic 
relationship with her sons’ father who did not approve of her decision to 
have bilateral mastectomies. He became abusive when she was going 
through treatment and now she and her children are on the run from 
him. Although she has a legal document in the form of a restraining 
order, she is fearful that he will find her. She has moved several times in 
the past few months. During one of these moves she fell through a porch 
and broke her ankle. Now she has mobility problems and is not able to 
move around as much as she would like. She has chronic pain issues 
from her reconstructive breast surgeries and recent injury. Celine feels 
that she has been disrespected and ignored by her doctors. She feels that 
there is systematic racism built into the healthcare system that leaves 
her feeling powerless.  
 Celine’s initial treatment was a lumpectomy and chemotherapy. 
She was told she was not responding to treatment and that her cancer 
was spreading. She was then scheduled to have 31 weeks of 
chemotherapy, however she only completed 29 weeks of chemotherapy 
before having surgery for her bilateral mastectomies and bilateral breast 
reconstructions. She is currently enrolled in a clinical trial and finishing 
the remaining weeks of her chemotherapy. Celine worked in the 
healthcare system for many years and now that she cannot work she 
describes having a significant reduction in her income.  She reports 
having Medicare and Medicaid and problems paying for her medication. 
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She is upset that she cannot support her children in the way that she 
used to. She plans to create some income by becoming an entrepreneur 
and starting a business that she can operate from her home.  
Interview with Participant 11: “Kara” 
Kara is a 49 year old divorced woman who was diagnosed two 
years ago and had a mastectomy for stage III-IV breast cancer. She lives 
with her boyfriend in a single family home. Her support system consisted 
of her boyfriend and two sisters. Her sisters supported her by taking her 
to appointments. Her boyfriend was supportive by cooking and cleaning 
the house while she was going through treatment.  She also had three 
adult nieces who took her to her physician and treatment appointments. 
Kara feels confident in her knowledge about breast cancer. She had a lot 
of experience taking care of her mother who died of breast cancer. When 
it came to treatment advice she only trusted her sisters and God.  She 
had chemotherapy for nine months and currently is taking Aromasin for 
five years. Kara reports having Medicare and Medicaid and no money 
concerns; she is able to pay for her medications.  
Interview with participant 12: “Elise” 
 Elise is a 78 year old divorced woman who was diagnosed eight 
months ago and had a lumpectomy for a stage II breast cancer. She lives 
alone in an assisted living facility. She has a sister and two adult nieces 
who are very supportive. Her nieces are both social workers and support 
her by taking her to her treatment and physician visits. Her sister 
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supports her by visiting, providing advice, and morale support. Elise is 
extremely proud of her education and experiences in life. She has always 
been independent and worked until she retired as a Dean in the school of 
sociology. She is an advocate of education and research. She and her 
nieces researched all of the possibilities for treatment before making an 
informed decision. Her treatment consisted of chemotherapy once a week 
for ten weeks to shrink her tumor before having surgery. She had a 
lumpectomy two months ago and has recently begun radiation. She is 
scheduled to have radiation five days a week for 3 weeks. She is 
currently on a clinical trial. Elise reports that she has Medicare and Blue 
Cross/Blue Shield insurance and no money concerns. 
Explication of the Grounded Theory 
The grounded theory for the treatment decision making process of 
African American women diagnosed with advanced breast cancer, 
consists of eight core categories: Diagnosis, Physician communication, 
Physician Trust, Physician Mistrust, Autonomous and Shared Decision 
Making, Paternalistic Decision Making, Fortitude, and Treatment Decisions 
(see Figure 1).  The Diagnosis is the procedure and methods utilized to 
find the evidence of breast cancer. This begins and drives the process of 
treatment decision making. Physician communication describes the 
informational manner and style employed by the physician(s) to deliver 
the diagnosis. This essential component lead to whether or not the 
women describe Physician trust or Physician mistrust. These categories 
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influence how participants chose one of two decision making pathways: 
the Autonomous and Shared Decision Making pathway or the Paternalistic 
Decision Making pathway. The first pathway, Autonomous and Shared 
Decision Making describes the physician-patient relationship in which 
the communication is two-way. The information exchange is a dialogue, 
options are given, and decisions are patient driven. There are four 
subcategories that influence Autonomous and Shared Decision Making:  
Family Support, Additional Information, Connections with Past Breast 
Cancer Survivor’s, and Spirituality. The second pathway, Paternalistic 
Decision Making describes the physician-patient relationship in which 
the communication is one way. The information is provided, there may or 
may not be a dialogue, options may or may not be given, and the 
decisions are physician driven. The one core category that influenced 
Paternalistic Decision Making: was Physician Trust. Fortitude describes 
how the women internalize and process the information, which allows 
them to build mental strategies to face treatment decisions.  It is the 
linchpin that connects all types of decision making and is integral to how 
the women proceed with their decisions. Women’s Treatment Decisions 
are the outcomes of the decision making process and are directly related 
to the potential success of the women’s treatment. 
Each major concept and its related subcategories will now be 
discussed in turn. Data excerpts will be provided to demonstrate the 
relationships within the grounded theory. Each excerpt will be label by 
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the participant pseudonym and identification number to facilitate the 
reader’s evaluation of dependability, transferability and confirmability. 
Fortitude in Treatment Decision Making 
Fortitude was the basic social process that emerged from this 
grounded theory.  This was the internal process that the participants 
needed in order to face the diagnosis and make the necessary decisions 
for their treatments. Fortitude is the first concept discussed, because 
Fortitude undergirds the grounded theory. Fortitude is defined in the 
dictionary as the strength of mind that enables a person to encounter 
danger or bear pain or adversity with courage (Merriam-Webster, 2012). 
Fortitude was a constant theme with all the participants and was evident 
in how they forged toward their treatment decisions thus their treatment.  
“You can’t just give up cause they say you got cancer.  Baby, you gotta 
keep on keeping on.  It’s got to come from within cause the doctors are just 
a tool of God.  The doctor don’t have the final say” (Lynn, 05,393-395). 
 
“I’m going, you know what, everything happens for a reason.  I said, okay 
I am going to go through it” (Anna, 03,67-68). 
 
Tenacity is also a synonym of fortitude and it sums up the women’s 
collective movement towards making their treatment decisions. 
“Two things, you have to force yourself to get up and do something.  You 
just can’t lay there….. The tenacity to hold on to life…..  Live again” 
(Joy,09,324-325;336-337). 
 
  
 
 
7
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Determination, strength, and grit are all synonyms of Fortitude and 
characterize to how the women rationalize their emotional journey in the 
decision making process. The participants were determined in their 
treatment plan.  
“You’ve got to be there for yourself, you know?  I think I did pretty good 
because you know sometimes they say, are you sure you want to do this?”  
(Lynn, 05,324-326). 
 
“Now that I know, the sickness is already here, but I am doing my best to 
deal with it, and keep going, and keep Christ in my life every day” (Anna, 
03.264-266). 
 
Strength was evident with this participant who reported how….she just 
knew that she had inner strength because of her daughter and because of 
her sister, and just for herself.  She is a very strong person and she did not 
want cancer to beat her, and so she wasn’t going to let it win. (Amy, 
08,191-193). 
 
Having that mental toughness or grit resonated with the participants. 
 
“You’re going to suffer some hard knocks.  You have to be a fighter, and 
I’ve been fighting – fighting – because I’m determined that I’m not going to 
let this beat me” (Celine, 10, 181-183). 
“I got tired and I was always tired a lot, but I never let it get me down.  I 
was tired but I would get up” (Maya, 06,280-281).   
“…the Lord don’t make no mistakes, and I’m still here, so I got a purpose” 
(Maria, 07, 308).   
“First of all, I come from a family where we don’t quit…….. And I was 
determined that I would not be in the wrong hospital and have a wrong 
team.  If it didn’t work, I would go tell them” (Elise, 12,540;572-574). 
The Diagnosis 
To understand the context of Fortitude and its importance, one 
must look at the total process that drives the decision making process 
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that emerged from the data. Hearing the Diagnosis for the first time was 
the beginning. 
“It was a tumor.  I always did a self-breast exam.  It started off as a little 
knot.  But instead of me going straight to the doctor, I waited until it got 
bigger.  I waited a couple months and it got bigger.  That’s when I went to 
the doctor and had an ultrasound and that’s when they saw the big mass 
in there” (Amy, 08,2-5). 
 
“I went in for the mammogram.  They said they saw something and I need  
to come in and get rechecked.  So, I went in and got rechecked.  I had the 
second mammogram and that’s when they said they really did see 
something.  So I went in for the initial needle biopsy.   The next day he 
called and told me over the phone that I had breast cancer” (Maria, 07,3-
7). 
 
 
For some participants it confirmed what they already suspected. 
“I knew I had it.  They didn’t know I had it, but I knew I had it” (Celine,10, 
295).  
 
“What they said was like it was fast growing, but I think I caught it kind of 
fast before I had a mammogram.  But I had went in the bathroom, you 
know how you feel yourself off and on, and I felt something and I went 
and got a mammogram” (Maya, 06,3-6). 
 
Going through the initial testing and subsequent biopsy was experienced 
by all the participants. Most times the mammogram and/or ultrasound 
along with the biopsy was completed in the same day.  
“I had an appointment downstairs to have my mammogram.  My whole 
day from 10 o’clock until after 4 o’clock that day it was like from one case 
to the other, they did the mammogram, and then they did the ultrasound 
and of course the radiologist checked it and she came back in and they 
said they wanted an ultrasound to check it and then they shared with me 
that the terminology as far as with the long needle to get a sample of the 
tissue, a biopsy, they put like a block on it so it would not hurt, but it did 
hurt” ( Joy, 09,4-9). 
 
For others there were a few days between the testing and biopsy.  
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“I felt a lump so I went to the doctor.  I went and got a mammogram and 
then a biopsy.  Once I got the biopsy, that’s when all of us went into a 
room and they told me” (Crystal, 04, 3-6). 
 
The next steps were confirming the Diagnosis and staging their disease. 
The American Joint Committee on Cancer (AJCC) sets guidelines for 
staging tumors (NIH; ACS, 2013). The disease staging involves (TNM) 
which indicates: the size of the tumor, the amount of lymph nodes 
positive for cancer, and any metastasis (NIH; ACS).  The participants 
were asked if they knew the stage of their breast cancer. Most of them 
did. 
“It was stage 2.  When he went in and removed a cyst from my left breast 
and found it was cancerous, he took out 2 of my lymph nodes and one had 
cancer in it also, and he had to go back in and remove the rest of my 
lymph nodes” (Anna, 03,12-15). 
 
“Well, they said the options but they said this one in the third or fourth 
stage or whatever it’s called” (Kara, 11,32). 
 
“He told me it was between stage 3 and 4” (Lynn, 05, 8).  
For some the diagnosis was not so clear. One participant explains: 
 
Not at first, but eventually mainly after the surgery is when I found out 
exactly what stage I was in for sure.  They were guesstimating… Yea, the 
doctor who performed the surgery said to him that’s what it could be, but 
to be for sure he would need to see the exact size of the tumor” (Diana, 01, 
6-10).  
 
The information sharing and exchange is a critical element with 
Diagnosis. Once the diagnosis is confirmed this process changes from 
static (listening) to dynamic, in that the participants now have to act 
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upon this information. Communication with the physician(s) is 
paramount. 
Communication 
 When the participants are going through Diagnosis, they try to 
grasp what is being said to them.  The amount of information is so 
overwhelming that some of the participants could not comprehend all the 
information.  
“The communication was good.  It was just, finding out I had cancer, 
everything else was just blah, blah, blah, blah, blah, blah” (Crystal, 04,15-
16). 
 
“So when I found out, I called Dr. ……, and first they were talking about a 
lumpectomy, and blah, blah blah, and all this stuff” (Celine, 10, 13-15). 
 
To glean information about the communication exchange between the 
physician and healthcare team the participants were asked:  “Describe 
your feelings about your communication with your health care provider.”  
 “I felt that he was very knowledgeable with what he was doing.  I felt 
comfortable with it” (Lynn, 05,14-15). 
 
“They were very very helpful in communicating with me.  Every test result, 
everything that they got, they gave it to me, even though I didn’t know 
what I was reading, but they would explain to me and everything” 
(Crystal, 04,103-105).   
 
 
Some of the participants’ describe communication interactions that were 
not positive.  One participant felt she was not heard by her physician: 
“My doctor – I feel like my doctor do for me what he wants.  I feel like he 
doesn’t take what I’m saying into consideration at all.  I mean, he’ll listen 
to me, but then he’ll say, ‘Ok, we have to do this because I think this is 
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better for you,’ or, ‘You shouldn’t be in that much pain.’  You don’t know 
how I feel, because you’re not me!” (Celine, 10,70-73).   
One participant felt she was not told the severity of her disease: 
“He didn’t tell me at this it was a stage 3.  I found out it was stage 3 when 
I read a report from Dr…….. to Social Security.  That’s when I found out it 
was stage 3” (Maria, 07,74-75). 
Another participant was upset and confused by the differing opinions on 
how to treat her breast cancer. Her initial physician said that she did not 
need any treatment but months later called her up and said that she 
needed chemotherapy and radiation. She saw a second doctor who 
confirmed that she should have had chemotherapy and radiation but the 
opportunity for that treatment was no longer an option. 
“I got a little angry with my oncologist because after my surgery he said I 
didn’t need any treatment, no radiation, no chemo, because it was so 
small.  Every couple of months I would go back for a checkup.  A couple 
months ago he flipped the script on me and said I needed chemo, and I got 
angry, and I’m like what?  So I got scared” (Diana, 01, 42-47). 
She goes on to describe her visit with the second physician: 
“I asked for a second opinion.  She told me that she feels the reason why 
he flipped on me was because of the size of the tumor…. But the only sad 
part is too much time had passed” (Diana, 01,52-56). 
Aspects of Trust 
 The communication interaction with the physician and healthcare 
team facilitated whether or not the participants’ trusted or mistrusted 
their physicians. These concepts were the lens through which 
participants viewed and responded in their decision making. These 
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physicians were not the participant’s primary care physicians. Therefore, 
these physicians were new referrals for the participants and there was 
not time to establish a relationship before learning they had a breast 
cancer diagnosis.  
Physician Trust  
 One outcome of communication with the physician was Physician 
Trust.  Participants described trusting that their physicians knew what 
they were doing.  When the participants were asked “Tell me about how 
much you trust your healthcare providers?”   
One participant gave a percentage: 
“100%.  It was Dr. N…. that was with me and Dr. A….. is the one who did 
my radiation after I went through the chemo.  They are the ones that I 
depend on” (Anna, 03, 50-53). 
 
Other participants described the same type of complete trust: 
 
“I guess I trust his opinion to a fault…… he was the one that was telling 
me, ‘I’m going to make sure you have all the help you need, and I’m going 
to make sure everything’s ok,’ and that kind of thing.  That’s what he told 
me” (Celine, 10,139-140). 
 
“……..it was just all new to me, but they were really open.  They would 
call my phone and talk to me, and doctors would come in and see me.  
They were good.  I could talk to them” (Amy, 08,79-81). 
On the other hand, Physician mistrust was just as prevalent with some 
the participants and influenced their decision making.  
Physician Mistrust  
 The participants were asked “How much they trusted the physician?”  
“In the beginning I didn’t because they were all new doctors, so I took the 
paper work they gave me to my doctor that I have been going to regularly 
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and let her look over it before I consented to the treatment” (Crystal, 04,38-
40). 
 
One participants’ trust was so violated that she did not question what 
she knew was a mistake in her diagnosis, ergo her treatment decisions. 
The participant was asked:  
“Did you ever call Dr. S… back and confirm and say I think this is a bit 
much for stage 1.  Did you ever confront her for an explanation?” 
 
“No, because the first person was wrong, and at least with the book as I 
was reading I could decipher and determine what was applying to me and 
what wasn’t” (Maria, 07,113-114).   
One participant only trusted the physician when her family was present.   
“I trusted them more when my sister was there with me” (Kara, 11,109). 
 Therefore, as the participants assimilated information they 
described their decision making pathway. However, these decisions were 
based on the initial information provided, and once more information 
became known some decisions could not be altered (for instances surgery 
decisions, whether or not the participants had a lumpectomy or 
mastectomy), because some of the additional information was received 
only after an irreversible surgery. This information led to the types of 
decisional pathways that were chosen by the participants and their 
influencing factors.  
Decisional Pathways 
Paternalistic Decision Making 
 With Paternalistic Decision Making encounters are described in 
terms of participants’ preference and/or reliance on the physician to 
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make their treatment decisions. When participants were asked “Who 
made the decision about whether or not you would have treatment?” Six 
of the participants describe Paternalistic Decision Making.  
“To tell you the truth, the way the doctors explained it to me, they laid a 
plan out for me.  They said this is what you need to do, .…. so I just said 
okay” (Amy, 08,50-53). 
 
 
“What happened was, Dr….. who did the surgery got in touch with Dr. ….. 
and she was the one that set everything up.   My breast did not have to be 
removed.  They just removed a cyst that was there.  A month later I started 
chemo” (Anna, 03, 57-60). 
 
“He told me that I would need to have treatment and I just wanted to do 
whatever it took just so I could be with my kids” (Celine, 10, 191-192). 
 
 “Dr C…. because of his thoroughness, and the nurse practitioner. He 
explained everything, the size of it, and that I had to have radiation ……..  
And I had chemo after that” (Joy, 09,90-93)  
 
Thus, Physician trust directly influenced this decisional pathway.  
While Paternalistic Decision Making was what six of the participants  
 
described, the remaining six participants described making their own 
decisions and being more involved in the process of treatment decision 
making. 
Autonomous/Shared Decision Making and Influencing Factors 
  
 There were several factors that influenced this type of decision 
making. These factors are described by the participants in tandem with 
their Autonomous and shared treatment decisions: Additional 
Information, Family support, Connections with past breast cancer 
survivors, and Spirituality. The participants who described Autonomous 
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and Shared decision making did so with confidence and conviction.  The 
participants describe that they were in control of their decision making.  
“I told them to remove the breast” (Kara, 11,35). 
 
“I primarily made that decision… at that time my brother had passed 
away and I was getting ready to go to Arkansas.  So between that and the 
fact that something had to be done, I made my own decision” (Maria, 
07,31;55-57). 
 
“Ultimately it was really up to me what I wanted to have done” (Teresa, 
02,41-42). 
 
 Additional information. Some of the participants sought 
understanding and utilized Additional Information to gather information 
about their disease: 
“I made the decision on my own……Once I got the literature from the 
internet and then meeting with the doctors and I made it because it is my 
body” (Crystal, 04,69-70). 
 
 
“I wasn’t prepared to have a mastectomy but after I talked to my doctor 
and I did some reading…. I didn’t want to have a lumpectomy in January 
and have to go back and have a ... you know, so I said, well, I don’t use it 
anymore, so whatever.  So, here I am.” (Lynn. 05,42-46).    
 
Family support. Family support was described by all of the 
participants in this study however, when it came to Autonomous and 
Shared decision making, what the participants families thought was as or 
more important than what their physician thought.  
“And then they did ask me then after a while– because I had talked to my 
sister and then they said, ‘well you should just probably go on and have 
the breast removed’ (Kara, 11,35-36). 
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“My niece went with me, so we was in there talking to the doctor together.  
To me it didn’t really matter, you know I wanted it off cause I didn’t want 
it to come back or nothing” (Maya, 06,32-34).   
 
The participants were asked “Who helped make your treatment  
 
decisions?”, two women responded: 
 
“My sister and my doctor, and my son” (Teresa, 02, 53).   
 
I follow what my niece tell me. “They told me what kind of treatment I 
needed so I went on and got the chemo and the radiation” 
(Maya,06,128;26-28).  
 
One participant describes a Shared decision making process with her 
family and healthcare team: 
“I had good input from my family and from me viewing the material…..  
Initially my plan was to have the chemo first, and then the surgery and 
then back to what I’m doing now…. So the second time they came back 
they came back with a lot more stuff.  You know, things in writing, all that 
kind of stuff.  So the three of us had things to look at, we could raise 
questions” (Elise, 12,142;206-207). 
 
Connections with past breast cancer survivors. Having a Connection 
with past breast cancer survivors was important to some of the 
participants as well. 
You know, I have a niece by marriage that lives in Baltimore.  When she 
first got the news that I was going to have surgery for this, she had a 
girlfriend, someone that she worked with has been through the same thing 
but she ended up having reconstruction.  She had her to call me and tell 
me some things that I could expect…. she stayed on the phone with me 
probably 3 or 4 times a week, you know just talking to me” (Lynn. 05,161-
172). 
 
“Well, two cousins.  One had breast cancer.   And my other cousin, she 
goes with me to all my chemo and all my radiation…. It made it easier, 
cause I could bounce my ideas.” (Maria, 07,187-190). 
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“Yea, it made it easier cause she was telling me what she had went 
through and how it affected her and I would see things and think oh she 
did tell me that, and it happened and stuff like that” (Maya. 06,49-51). 
  
One participants’ knowledge came from personal experience. She took 
care of her mother who died of breast cancer. 
“.. well she had…My mother, they got rid of it, and then hers came back.  
They said that she was supposed to only live for like five years but she 
lived longer than that.  My mother passed away at the age of 77.  Hers 
came back in another place though because when they diagnosed her with 
the breast cancer for the first time, she just went ahead and had both of 
hers removed even though the other one didn’t have it” (Kara, 11,183-187).  
Spirituality. The expression of Spirituality as evident in how the 
participants made their decisions and garnered divine strength. When 
asked how did you make the decision about what you were going to do? 
One participant said: 
“Talked to the man up there….“So, you just prayed about it? Yes.” (Maria, 
07, 179-181). 
Being unable to participate in church was hard for one participant. 
“It seemed like on Sunday when I could not go to church, I would sit here 
and that’s when the hard times would come.  I would get so depressed.” 
(Anna 03,107-709). 
 
Having a strong spiritual foundation was paramount to one woman. 
 
“That’s why I have to read the word and all the scriptures on Him.  Doctors 
give facts but the truth is, by His stripes I’m healed.   That’s what I’ve got 
to lean on.   I use the position for the youth.  It still takes God, even with 
medication.” (Joy,09,143-147). 
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Women’s Treatment Decisions 
 Women’s treatment decisions were based on all of the 
aforementioned components. This grounded theory highlighted that this 
treatment decision making process is reciprocal. After the treatment 
plans are laid out any additional decisions would start the process all 
over again.  Sometimes the women had to make decisions based on 
whatever information was available at that particular time. However, if 
any new diagnostic information became available, this would then drive 
communication with their physician and the need to choose a decisional 
pathway again (see Figure 1). One women describes paternalistic 
decision making with her initial diagnosis….  
 
“They basically made them.  I didn’t make any.  I assumed I was going to 
go right into chemo or radiation after my surgery but when they said I 
didn’t need any I said oh, okay.  I left it mainly up to them” (Diana, 01,96-
98).   
 
…and described shared decision making after additional diagnostic 
information revealed that she was at a higher stage than originally 
thought. 
  
“Then I met with an oncologist, and the oncologist gave me choices.  
Then he told me what was going to the happen and the choices that I 
had.” (Diana, 01,16--22).   
 
 
Research Questions 
 This section will address the research questions initially proposed 
for this study to describe the treatment decision making process. In 
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grounded theory the initial research questions provided a basis for 
analysis. As the study evolved some of the research questions were more 
pertinent than others. Several of the interview questions were changed or 
removed to highlight the emergence of the grounded theory (see 
Appendixes A-B for interview guides). 
Research question 1: How do African American women describe the 
process of making decisions about breast cancer treatment? 
 Participants described their treatment decision making in a myriad 
of ways. It was imperative to understand their processes in a coherent 
way to capture the phenomenon. The components of the treatment 
process the women describe were discussed in the section Explication of 
the Grounded Theory. In order to understand the phenomenon 
thoroughly five additional questions were asked and will be answered 
below. 
 1a. How do women participate in treatment decisions? Participants 
described various levels of participation in their treatment decisions. Half 
of the participants described autonomous decision making. They 
explained reading and looking up material prior to making their 
decisions. Other participants described paternalistic decision making 
where they voluntarily give the physician permission to make the 
decision(s) regarding their treatment. Other participants described 
paternalistic decision making where they felt powerless and did not feel 
they had the autonomy to make their own decisions. Finally, there were 
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several participants who vacillated between autonomous and shared and 
described a combination of both types of decision making (see Table 4).  
Table 4 
  
Types of Participant Decision Making Styles 
 
Decision Making Style Number 
(% of sample) 
Autonomous Decision Making 5 (42%) 
Paternalistic Decision Making 6 (50%) 
Shared Decision Making 1 (8%) 
Autonomous and Shared Decision Making 2 (16%) 
Paternalistic and Shared Decision making 1 (8%) 
 
 
 1b. How is a woman’s participation in their treatment decisions 
facilitated? Facilitation with treatment decisions for these participants 
came from more than one source. Participants described being assisted 
with their decisions by family, friends, communication with their 
physicians, independent research (see Table 5), trust in their physician 
or several combinations of these factors. The facilitation was tied to the 
decisional pathway described participants. For the participants who 
described autonomous decision making, they described being assisted by 
family and independent research. For the participants who described 
paternalistic decision making, they described being assisted first by 
communication with the physician, trust in their physician, and lastly by 
family and friends. Finally, the participants who described shared 
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decision making described being assisted by communication with their 
physician, family, and independent research.  
Amy (08)  praised her doctors, really cared for her doctors, continues to 
take the time to call her doctors, even her oncologist and the radiologist to 
talk about her progress and to talk about what is going on with her(184-
187). 
 
Table 5 
 
Types of Additional Informational Resources  
 
Types of additional informational resources  
Internet: 
And then I looked online and did a lot of research. 
(Diana) 
 
Books: 
The books they gave me one of them I call it my chemo 
bible. (Anna)   
the books they gave you were pretty thorough (Crystal) 
I read books.  (Lynn) 
I read a lot of books (Celine).    
Books (Elise) 
 
Pamphlets: 
I read the pamphlets they gave me (Teresa) 
Pamphlets (Elise) 
 
Movies: 
I came home with movies (Lynn)  
 
 
1c. How is a woman’s participation in their treatment decision 
hindered? To gain insight into this question the participants were asked 
to describe, “Who made their decision harder or worse”? None of the 
participants were able to give an answer to this question. Because of the 
nature of breast cancer, some decisions were made quickly after 
diagnosis. In these instances, participants did not feel that anything 
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hindered a decision. Therefore, to capture a problem with decision 
making, the question was re-framed to “How comfortable were you with 
the treatment decisions that were made?” to which several participants 
spoke about not being satisfied with their decisions (i.e., having 
decisional regret). There were several factors that were germane to 
dissatisfaction with their decisions including being given false or 
incorrect information at the time of diagnosis,  
“That’s what I wondered.  You know, was the machine just misdiagnosing 
me and saying that I was clean when I wasn’t?  Because I have had it 
done every year for over 20 years.  In fact, I am wondering were they 
growing in my lymph nodes the whole time.., you know, because there’s 
no way they could… When they were doing the mammograms they could 
see in there.”(Maria, 07, 270-273). 
making hasty decisions, losing trust in their physician, losing confidence 
with their initial decision, and not having enough knowledge to make an 
informed decision.  
“My stepdaughter asked me that, because she thought the mastectomy, 
everything happened so fast.  Within 2 weeks I had had a mastectomy.  I 
was diagnosed on like the 19th of December last year and before 
Christmas I had had my breast removed….It was extremely fast and she 
thought maybe I should have waited, but I don’t know and I’m not quite 
sure.” (Diana. 01,79-82). 
 
 1d. How do women describe their patient-physician communication 
and interaction in relation to treatment decision making? The participants 
were thorough in their descriptions regarding communication with their 
physicians. They remembered in vivid detail how they were diagnosed 
and what their interactions were with their various physicians. The 
communication was described as being either positive or negative. The 
participants who described positive communication with their physician 
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described being comfortable speaking to and asking questions of the 
physician(s). They also described getting positive feedback from their 
physician. 
“He will tell me stuff, you doing good, better than the rest of them, you 
know stuff like that.” (Maya, 06,126-127).    
 
Others described negative communication with their physician such as 
breakdown in communication, lack of communication, feeling 
disrespected, language barriers,  
“And I think it would be helpful if, when there’s a language difference 
between the patient and the staff person –if there was an English person 
there to help facilitate that.” (Elise, 12. 108-110). 
 
and being unable to discussion their cancer progress. One woman 
reported: 
“My surgeon didn’t talk to me about nothing” (Lynn,05,91). 
 1e. What additional resources do they utilize in making their 
treatment decision? Participants identified survivor support as being a 
key factor in helping with their treatment decisions. In addition, the 
participants used their interactions with past survivors as a way to gage 
their treatment plans. They were able to ask questions of their 
physicians based on information gleaned from past survivors. Some of 
the participants valued and followed what the past survivors told them 
over what their physician instructed. 
“Sometimes the medication, pain pill, make me constipated so I told him 
don’t give me that no more, give me something else, and he asked me why.  
I say cause I be constipated.  He say, oh yea I forgot to tell you that.  I say 
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yea I know my niece told me.  I said I don’t want that no more so he gave 
me another prescription for something else.” (Maya, 06,144-149).  
 
Research Question 2: What factors of cultural capital do women 
utilize when making treatment decisions? 
 
 A detailed explanation for cultural capital can be found in the 
section title “Conceptual Framework”. In review, the definition of cultural 
capital is people’s symbolic and informational resources for action 
(Bourdieu, 1986). It is further explained as ‘resources’ in the forms of: 
knowledge, operational skills, linguistic styles, values, norms, education, 
and advantages that a person has acquired through life long socialization 
(Abel, 2008). It was imperative to assess what forms of cultural capital 
these participants utilized in their decision making. In the current study, 
the main cultural capital that all of the participants accessed was in the 
form of fortitude. This theme was evident in their decision making 
process and explained earlier in the section “Fortitude in Treatment 
Decision Making.” There were other types of cultural capital accessed to 
assist the women in their decision making. The following questions were 
developed to specifically outline how this was accomplished.   
 2a. What social supports do women utilize when making treatment 
 decisions?  One important type of culture capital for these 
participants was in the form of family support.  In addition, the added 
capital of being connected with past breast cancer survivors was an 
unexpected finding. The participants oftentimes depended completely on 
the advice of the past survivors and held on to their words, which 
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increased their fortitude. Finally, the additional capital of spiritual 
support was essential to many of the women as a foundation that was 
used to increase their fortitude as well (see Table 6). 
Table 6 
  
The Descriptions of Social Capital-Spiritual Support  
 
Participants Descriptions of Social Capital-Spiritual Support 
Attends church:   
I got spiritual support from my pastor and my church family (Anna) 
I’ve been active in my church all my life (Elise) 
I go to church and they pray for me and stuff, and I had good support (Maya) 
I am a pastor of a church with three locations (Joy) 
I go to church. I am Baptist (Kara) 
Reading the bible:  
I read the bible a lot (Teresa) 
I have a prayer bible that you pray with the word (Joy) 
What I do some days I read a chapter, some days two, depends on what I’m 
reading (Lynn) 
Prayer:  
My mother is a Jehovah’s Witness. I did talk to Jehovah’s Witnesses at one 
time (Teresa) 
My aunts that would come and pray for me (Amy) 
TV ministries. I call on the hotline and get support. (Celine) 
One of my friends, she’s an Evangelist and she comes to visit me (Celine) 
I have 5 am prayer that I listen to. We had prayer today at 3 pm and I go to 
my girlfriends’ church and they have prayer at 7 pm. (Joy)   
Spiritual beliefs: 
“That the Lord don’t make no mistakes, and I’m still here, so I got a purpose” 
(Maria)    
“My inspiration comes from Him getting me up out of bed every day.” (Lynn)  
“That’s why I say you must have God in your life.” (Anna) 
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 2b. How do economic circumstances affect treatment decision 
making? Seven of the participants did not feel money was an important 
factor in the treatment decisions. However, five of the participants that 
expressed concerns, the concerns came from not having insurance or the 
money for copays required for visits and or medication. When asked 
“What money concerns do you have?” 
 “…at the time I did it could have been the fact that I was unemployed and 
didn’t have insurance at that time” (Maria,07, 154,155). 
 
 and, “What concerns do you have about paying for care and/or 
medicine?” one participant explained: 
“There is always concern with your co-pay.  Because when you have bills 
and your credit goes down the tube because of sickness.  And when they 
give you 30 days and turn things over to collection, and you have 
insurance, it don’t mean nothing until you give them money and you can 
expect it.  But I do have a problem when the collector calls and there is no 
compassion or empathy” (Joy, 09, 168-171).   
 
‘The only drug I worry about is medication that I take to help me walk 
which is $1300 a month for 30-day supply.  I am going to call the drug 
company that makes it and they will be able to help me” (Anna, 03, 188-
191). 
 
2c. How do important cultural values or beliefs influence women when 
 making treatment decisions?  Many of the participants in this study 
were not able to answer this question in a meaningful way. When asked 
“Tell me about any specific beliefs or personal values that were important 
to your treatment decisions?” most of the participants spoke about their 
spiritual beliefs. A few women gave information on their personal beliefs 
but they did not specifically feel it was a belief held by their cultural 
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society. One participant explains about her belief in the changes she’s 
made in her life. 
“The things I used to do, I don’t do them no more.  I tell you, if I met the 
person that I was 40 years ago, I wouldn’t like her.  I love me!  I can live 
with me now.  You know what I’m saying?  I have did a transformation 
baby.  It’s a shame to say, but I think my health is what made me 
transform to who I am today.  And too bad I couldn’t have did this when I 
was healthy and moving around” (Lynn, 05, 270-275).   
 
Another participant believes we get cancer from food: 
“Myself, I think it’s a lot of this food you be eating.  I really believe that.  
They put all this stuff in the food and I would not a ate a lot of stuff.  
Cause you can get a chicken born one month, and the next month you 
eating it.  When we was coming up you didn’t eat no chicken that fast.  
They putting all this stuff in them to make them grow fast and that stuff 
get in your body so it change your body and stuff.  I always believe that 
(Maya, 06, 225-230).   
 
 2d. How do cultural concerns influence their treatment decisions? 
This question was asked to highlight any connections between perceived 
racism and its effect on their decision making. During the interviews I 
would have to restate this question and explain what I meant each time. 
Therefore, when the participants were asked “Do you feel like the 
treatments that you have received are any different because of your race? 
The majority of the participants were emphatic that this was not the 
case. They felt comfortable with how they were cared for during their 
treatment visits. They would comment on how grateful they were for the 
professionalism of the staff. However when one participant was asked 
specifically about racism she explained how she was treated based on 
her treatment status and looks: 
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“I think if I wouldn’t have been a test bunny, I would have got treated 
worse.  I’m sure I would have.  But I was a test bunny because I was in a 
case study.  That’s what I call them.  That’s what we call them in the 
hospital too.  So I think –  
Q: - So you think because you were in a clinical trial, you got treated 
better, but you felt like because you were black you probably would have 
been treated worse? 
A:  Bingo! And there’s a lot of nurses that are not like that but there were 
so many of them that you could just feel it.  They acted like they were 
scared to touch me.  Oh boy, and then when I tell them that I’m an ICU 
technician but that I just don’t work at the hospital anymore, then 
everything is, ‘Wow.  Ohhhhh!’  Yea.  See, but they were looking at me 
with my nose being pierced and my eyebrow being pierced and the 
earrings in my ears and my hair color, because I’ll go from purple to pink 
to green to blue to orange….that’s just me” (Celine,10, 340-350). 
 
Another participant felt there was inherent racism in a particular 
institution and that racism played a part in how she was informed of her 
diagnosis and then subsequently misguided through this particular 
institutions’ healthcare system. So during her story when asked ‘”o you 
feel like your race had anything to do with it?” She explained: 
“To me, it was. Now everybody know R…Memorial is a killing hospital.  
Everybody know that.  But, I was with Dr. S… and she was with 
R……Memorial for so long til when I was getting my mammogram it was 
just easier to just keep going to the place that I was going to.  Stupid me!   
And by me being a layman and new to that part of the game, I didn’t know 
that I should have consulted an oncologist before the surgery.  So in my 
layman’s terms I’m thinking well, since they referred me to Dr. M… 
(surgeon), then he already know the deal and he go’n tell me, but no.  I 
went from surgeon to oncologist.  So the damage was pretty much already 
done when I got to Dr. S… (oncologist).  So that’s probably why we went at 
an accelerated rate….. This doctor was recommended because they said I 
needed surgery.  No mention ever came up from the radiologist or anyone 
in that room to contact or to get an oncologist until I went to Dr. M… (after 
my surgery) and he asked me did I have anybody in mind, or he could 
recommend somebody”  (Maria, 07, 131-147).  
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Additional Findings 
 
 An additional finding of risk assessment was noted after four of the 
participants were interviewed about genetic testing. Genetic tests can 
check for BRCA1 and BRCA2 mutations in people with a family history of 
cancer that suggests the possible presence of a harmful mutation in one 
of these genes (NIH, 2014). Three participants reported being tested. Two 
participants did not have the gene. When asked about genetic testing one 
participant reported she had been tested. When asked about “knowing if 
she had a family history?” she stated: 
“Not of breast cancer.  I have a family history of emphysema.  My 
grandmother died of lung cancer.  But like nobody had breast cancer. 
Mammograms are not recommended until age 40, so the doctor said it was 
rare for a female my age” (Amy, 08, 60-62).  
 
The other participant responded: 
 
“No. I don’t have the genes, family history. I don’t know where. It’s such a 
shock” (Crystal, 04,190-191).   
 
The third participant was positive for the BRCA gene and therefore had a 
double mastectomy along with a hysterectomy to manage her cancer 
risk. When asked about “whether or not her mother had breast cancer?” 
she responded: 
“No, she had ovarian cancer….. So, because she had that and breast 
cancer ran in my dad’s family, I got the double whammy.  So I have an 
overactive cancer gene.  So that’s what took everything from me” (Celine, 
10, 207-210). 
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The forth participant did not remember being tested even though her 
mother had been diagnosed with breast cancer twice. When asked “Did 
her mother or sister have breast cancer?” She stated 
“My mother….. She had both of hers removed… they got rid of it, and then 
hers came back.  They said that she was supposed to only live for like five 
years but she lived longer than that” (Kara,11, 39,42,183). 
 
When asked “Did you look up more information because your mother 
had breast cancer?” She responded: 
“No, because I knew a lot of it from my mother” (Kara, 11,179). 
 
This participant did not seem to relate her risk for breast cancer to her 
family history.   
 
Chapter Summary 
 This chapter describes the grounded theory “The Treatment 
Decision Making Process of African American Women Diagnosed with 
Advanced breast Cancer.” Each major concept and its related 
subcategories were presented. Characteristics of the sample and a 
synopsis of each the participants were provided. Finally, an in-depth 
discussion of how the data addressed each research question was 
provided.   
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Chapter Five 
Discussion and Recommendations 
The grounded theory study of Treatment Decision Making in African 
American Women with Advanced Breast Cancer (see Chapter Four) 
yielded three major findings about the Treatment Decision Making 
process including: 1) Emergence of the basic social process of Fortitude, 
2) How integral communication was with the physicians and/or 
healthcare teams, and 3) The dichotomy of physician trust and mistrust 
from this communication. In addition, integration of the findings with the 
framework cultural capital yielded several important subcategories 
including: connections with past breast cancer survivors, family support, 
spirituality, and information regarding risk assessment. This chapter will 
first discuss the findings in relation to the literature and the study’s 
conceptual framework. Then, the study’s limitations will be outlined. 
Third, implications for nursing practice will be provided. Lastly, 
recommendations for future research will be presented.  
Integration with the Literature 
An appraisal of the findings of this study will be provided based on 
related literature. The concepts of patient-physician communication and 
physician trust and mistrust will be will be compared with the existing 
decision making literature. Next, the grounded theory of Fortitude will be 
discussed. Finally, a discussion on the additional findings of this study 
will be addressed. 
103 
 
 
 
 
Patient-Physician Communication 
 
This study found that the communication interaction between the 
participants and physician or health provider team was complex in that 
it could be both positive and negative in a single encounter. In addition, 
this communication process was vital because it provided a range of 
information yet it could be difficult because the informational messages 
were overwhelming. This was comparable to research by Sheppard, 
Adams, Lamdan, and Taylor (2010) that found patient-provider 
relationship was the most notable factor that influenced treatment 
decision making. Specifically, the women’s relationships with their 
providers influenced their knowledge about their diagnosis, perceived 
efficacy about treatment, understanding of their treatment options, and 
their acceptance of and subsequent adherence to recommended 
treatment. The current study was divergent from research by Williams et 
al. (2008) which found that in order for communication to be effective the 
physicians had to first establish a relationship with patients and families 
facing cancer. The participants in this current study did not describe 
having time to establish a relationship with their new referred oncologist 
and surgeons. 
Physician Trust/Mistrust 
This study showed a dichotomy between physician trust and 
mistrust. Where trust was described by participants who preferred a 
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passive role in decision making and mistrust was described by 
participants who preferred a more active role in decision making.  
This was similar to research by Kraetschmer, Sharpe, Urowitz and Deber 
(2004) which found that respondents who wished for an autonomous role 
in decision making tended to have lower trust in their providers. And 
those participants who desired a more passive role in decision making 
had higher levels of trust. Similarly research by Kaiser et al. (2010) found 
that participants reported high levels of trust in their regular physicians 
and an even greater trust in their cancer diagnosing and treating 
physicians. 
This was in contrast to research by Arora and Gustafson (2008) 
who found that patient trust changed over time. In the time period closer 
to diagnosis, informational, emotional and decision making support from 
physicians were all significantly associated with patient trust. However, 
at the two and five month’s assessments decision making support was 
not associated with trust. The current grounded theory study did not 
assess time in relation to trust, since data were collected primarily from a 
single interview. 
Fortitude 
 The basic social process of Fortitude underlies the decision making 
process for African American women facing an advanced breast cancer 
diagnosis and treatment. The discussion on Fortitude and its 
embeddedness is found in Chapter Four. 
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Additional Findings 
Decisional Pathways 
Variations in the patterns of decisional involvement and decisional 
preferences, were present in the tenents in the seminal research by 
Denger et al. (1997) where women describe a substantial discrepancy 
between their preferred and attained levels of involvement with breast 
cancer treatment decision making. Half of the participants in this study 
describe Autonomous and Shared Decision Making, while the other half 
described Paternalistic Decision Making. Even with these robust 
descriptions there were still other participants who described a 
combination of the decision making pathways outlined above. This is 
consistent with the research by Hawley et al. (2007) where women report 
variations in their actual decisional involvement in breast cancer 
treatment decision making, which resulted in a discrepancy between 
patients’ actual and preferred levels of involvement. This current study 
was also congruent with research by Vogel, Helmes, et al. (2008) which 
found that newly diagnosed breast cancer patients preferred the 
physician to make the treatment decision. This study differs from 
research by O’Brien et al. (2008) which found complex treatment decision 
making processes with most of the women having viewed the physician 
treatment recommendations as giving them confidence in their own 
treatment decisions, resulting in the women having sought their 
physician opinion.  
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Information needs. Informational needs were an important factor 
for participants who described Autonomous and Shared Decision Making 
as was found in the seminal research by Bilodeau and Denger (1996). 
Specifically, participants in this current study describe performing 
additional research before making Autonomous or Shared treatment 
decisions, was consistent with research done by Spittler, Pallikathayil, 
and Bott (2012) which found that women viewed information needs as 
very important and often chose treatments that most likely would 
enhance their life expectancy after being diagnosed with breast cancer. 
This differs with research by Lally (2009) which found women described 
gathering information to become knowledgeable about breast cancer and 
treatment options even before hearing the surgeon’s initial explanation of 
the new diagnosis and treatment options. Furthermore, in research by 
Vogel, Bengel, et al. (2008) the informational needs of the patients 
changed over time. Where there was a decrease in the importance of 
specific informational needs over a six month timeframe.    
     Integration of the cultural capital finding with the literature. 
Understanding the relationship between cultural associations and 
decision making was relevant to this study population as with the 
research done by Fowler (2006b). The literature describes social capital 
as one of the forms of the cultural capital framework. This is where 
group membership, relationship, networks of influences and support are 
garnered (Bourdieu, 1986). The participants in this study describe social 
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capital in the form spirituality where going to church, prayer and belief 
in God (see Table 6) were germane to their treatment decision making. 
This was congruent with research by Lynn, Yoo, and Levine (2013) that 
found women who belonged and did not belong to a religious institution 
talked about how spirituality and prayer helped them cope with their 
illness. This was also similar to research by Roff, Simon, Nelson-Gardell, 
and Pleasants (2009) which found that the women received 
religious/spiritual support from a variety of sources. Specifically, they 
reported support from God, congregational members and their clergy. 
However the current study differs from research by Simon, Crowther, 
and Higgerson (2007) which examined stage specific spirituality and 
found that spirituality was a key component in women’s coping process 
from diagnosis through recovery and on to survivorship. This current 
study did not assess spirituality apriori to their breast cancer diagnosis.  
Family support. The participants in this study were very clear in 
describing how supportive their families were with their decision making 
and throughout their treatment regimens. This was supported by 
research from Maley et al. (2006) and Hawley (2009) that evaluated the 
role of the patient’s family and friends in decision making and receipt of 
surgery for breast cancer. Their research found that women of different 
racial and ethnic backgrounds indicated that the opinions of their 
spouse, family, and/or friends were important in their decision making.  
This is further supported by research from Lillie et al. (2014) which 
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found that most partners positively appraised their experiences across 
the elements of the treatment decision making process, as the majority 
reported receiving sufficient information, having a high amount of actual 
involvement in the decision process, and feeling that this amount of 
involvement was sufficient. It is important to note that there is limited 
literature on the concept of family support in the context of treatment 
decision making in breast cancer for African American women.  
Connections with past breast cancer survivors. This study 
found that for most of the participant’s their connection with past breast 
cancer survivors was an important factor. Participants reported how this 
connection reduced anxiety, increased participants’ sense of control, and 
provided a valuable source of knowledge about the treatment process. As 
stated by one participant who connected with a breast cancer survivor:  
“…this was somebody that didn’t know me, never met me, but she stayed 
on the phone with me probably 3 or 4 times a week, you know just talking 
to me.  That long distance, not knowing a person, that was some valued 
friendship and information.” (Lynn). 
 
Participants reported several reasons why they trusted the survivors.  
The most common reason was that the survivors could relate to having 
breast cancer. Alternatively, participants who did not report connection 
with past breast cancer survivors either had no one they knew with 
breast cancer or did not speak to this in their interview. Therefore, it is 
unknown why these participants did not utilize past survivor support as 
an option in their treatment decision making. Interestingly, there is no 
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published literature that examines African American breast cancer 
survivors that serve in a role of assisting other women diagnosed with 
advanced breast cancer with treatment decision making. This finding 
suggests several future avenues of inquiry including: why newly 
diagnosed women place such implicit trust in survivor’s advice, how 
important this role of support is for newly diagnosed women, how this 
relationship potentially affects treatment decisions and what other 
consequences (positive or negative) can result from these relationships. 
Being it is not common for nurse navigators to help facilitate newly 
diagnosed women to make connections with survivors, it will also be 
important to explore what training the survivors should receive in order 
to maximize interacting with newly diagnosed women in supportive ways. 
Conversely, it will be important to explore the degree to which the trust 
between a newly diagnosed woman and a survivor resonates when 
survivors are family members versus non-family members.   
Risk Assessment 
The findings regarding risk assessment were evident with only four 
of the participants however, these findings were analogous to the study 
by Spector et al. (2009) which compared breast cancer risk perception 
between Caucasian and African American women with a family history of 
the disease. Specifically, the study examined how perceived risk relates 
to risk reduction behaviors. Spector et al. found that most women 
perceived themselves to be at increased risk for breast cancer and more 
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African American women (66%) than Caucasian women (30%) perceived 
their risk as moderate to high. In comparing Caucasian women and 
African American women the investigators noted that according to the 
Gail Model 5 year risk estimates, 90% of Caucasian women and 33% of 
African American women were clinically at increased risk for breast 
cancer.  
Risk perception for the participants in this study was not 
measured, however healthcare providers view family history of breast 
cancer as an important rick factor. This was a disadvantage for the 
women in this study perhaps because if they were aware of the risk 
factors they might have made the decision to seek breast healthcare 
sooner. As in the Spector et al. (2009) study women who perceived their 
risk were more vigilant in seeking care. This current study demonstrates 
that awareness of breast cancer risk factors should be a foremost 
initiative of healthcare providers and advocates for breast cancer.  
Other Findings 
 There were several other findings in this study that warrant further 
exploration in future research. First there were several participants who 
were diagnosed and then were later told that they needed additional 
treatment. There were three participants who were given a diagnosis and 
then found out that the initial information was either incorrect or not 
communicated by the physician. Diana felt she was misdiagnosed. She 
was given an initial diagnosis and 7 months later told that she had a 
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more severe diagnosis and now needed chemotherapy and radiation. 
Maria was first told she had breast cancer over the phone. Next, she was 
never referred to an oncologist. Lastly, her surgeon never disclosed her 
breast cancer stage, instead, she learned this information by reading her 
medical record. Another participant, Joy, was told to have a breast 
conserving surgery lumpectomy by one physician. She was then told to 
have a mastectomy by another physician. She decided to go with the 
physician who recommended the lumpectomy but was later told she was 
not responding to treatment and should have had a mastectomy. She 
then had the mastectomy, chemotherapy, and radiation. These 
participants’ disparities in diagnosis is congruent with research by 
Fedewa et al. (2011) which found that African American and Hispanic 
women had higher 30 to 90 day diagnostic delays than Caucasian 
women for stages I to III breast cancer. These investigators found these 
delays were due to access to care, specifically patients that were referred 
to the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP), geographical distances to the treatment facility, and cost 
barriers. 
 Another finding included several participants who did not seek out 
family support for their decision making. Those participants who choose 
paternalistic decision making did not describe family as being germane to 
their decision making. However, these participants reported family 
support for treatment. When making decisions, this group of participants 
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all reported physician trust as being the most important factor. It is not 
clear from the data who had family present during the physician 
consultations, at the point of diagnosis. Inquiring into this area in 
greater depth is recommended in future studies.   
Limitations 
While the results of this study provide insights into the decision 
making process for African American women with advanced breast 
cancer, there were several study limitations. The first limitation was the 
small convenience sample. This small sample limits generalizability to 
other populations, although being a qualitative study, transferability was 
prioritized over generalizability. Secondly, this study focused on African 
American women who received treatment in an urban area with relatively 
easy access to care. This sample may not be representative of African 
American breast cancer patients in rural areas or women with barriers to 
care. Third, inclusion criteria for the study included women who were 
already in treatment or had previous treatment in the past four years 
who reported treatment compliance. Study findings could potentially 
differ among women who decline treatment or have withdrawn treatment.   
The forth limitation involved variations in elapsed time between 
diagnosis and participation in this study. Participant’s interviews were 
retrospective reflections of their decision making process, and views were 
likely informed by the many experiences of diagnosis and treatment since 
the initial diagnosis. The decision making process may have been 
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different if all the participants were discussing their experiences current 
with actually making those decisions instead of reflecting back on those 
decisions. The participants in this study were unable to articulate their 
cultural views. This might be because of the embeddedness of racism in 
their interactions with their physicians and engagement within the 
healthcare industry on a consistent basis that they were unable to 
recognize this as problematic or felt uncomfortable stating this as a 
reality. 
A final limitation was the absence of the role of the nurse in the 
participants’ descriptions of their decision making process. It is known 
that the participants came in contact with nurses at several points in 
their decision making process. However, their descriptions did not reveal 
these relationships. All of the participants were highly articulate about 
the relationship with their physicians. Yet, the support participants 
received from nurses mainly centered on their treatment experiences. 
Nursing needs to seek new and more meaningful ways of engaging with 
patients to change patients’ perceptions and experiences with breast 
cancer treatment decision making. 
Study Strengths 
A strength of this study was the breadth of characteristics of the 
sample. The participants that were interviewed had diverse experiences 
with the decision making process. Beyond diverse experiences, there 
were wide variances marital status, age range, income level, and 
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education among participants (see Table 1). The richness of these data 
was illustrated in the theoretical model (see Figure 1).  
Implications for Nursing Practice 
Findings from this study provide nurses with a more thorough 
understanding of the decision making process in African American 
women facing advanced stage breast cancer. The need for more positive 
communication in the initial interactions with patients at the point of 
diagnosis by nurse navigators and all members of the healthcare team 
cannot be overstated. The model for treatment decision making shows a 
need for understanding the cultural supports that aid in decision making 
and helping to facilitate these connections so that patients optimize the 
cultural capital those supports can provide to the patient during this 
challenging time. Findings also suggest that nurses consider linking 
newly diagnosed patients with past breast cancer survivors as early in 
the decision making process as possible. Also, providing more guidance 
with written and oral communication and explicit directions about the 
selected treatment options is a key facilitator that would benefit patients. 
Nurses are in a position to offer their breast cancer patients direct and 
thorough answers to patient’s questions. Follow-up telephone calls to 
reinforce teaching and availability and openness to answering additional 
questions have proven successful. Furthermore, there is a need for 
breast cancer patients to have anticipatory post-treatment information, 
guidance and support on multiple levels. 
115 
 
 
 
 
This study was conducted in a cancer center. Another implication 
this study findings offer involves setting protocols for how to 
communicate with patients within diagnostic and treatment centers. The 
lack of consistency in communication to patients suggests the need to 
increase continuity within communication to patients from the point of 
receiving diagnostic results through the treatment process. Such 
continuity would involve coordinated efforts from nurses in the 
diagnostic center, including nurses in the roles of, navigator, treatment, 
and radiology. Patients require multiple steps in their progression 
through the different levels of care. For example, those patients who 
enter into clinical trials should have research nurses included in 
communication protocols. Communication protocols need to address 
many issues including, who is present when the patient is given their 
breast cancer diagnosis, and perhaps a team approach would be 
beneficial. 
Another implication from this study is that the nurse’s role in the 
diagnosis process should involve providing more information to the 
patients as they come in for diagnostic mammograms and/or subsequent 
breast cancer diagnosis. Examples of information that could be gleaned 
from patients in this setting include: a) Assessing the timing and flow of 
information; specifically, how much information they want and when 
they want it; and b) Assessing what other support patients need such as   
information about the process and what other steps might be involved.    
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Implications for Policy 
This study was conducted at a time when new federal laws in the 
Affordable Care Act (ACA) were being implemented. There are policies 
surrounding breast cancer treatment that are in flux, given there are 
several potential unknown implications of the ACA. The first implication 
is the NBCCEDP that provides funding and services for women who meet 
income guidelines (usually women with no or low- income). Whether this 
program will continue or be changed is unknown. Research by Levy, 
Bruen, and Leighton (2012) found that even with the increased number 
of women transitioning from being uninsured to insured, the NBCCEDP 
programs in Massachusetts, for example, would still only be able to serve 
one-third of the remaining uninsured women eligible for services. The 
NBCCEDP is a grant program and its funding is limited to federal and 
state appropriations; the program has never had sufficient funds to serve 
all eligible women. Instituting the ACA is projected to only marginally 
affect these eligibility numbers. This program is important for treatment 
because once a woman is diagnosed there are problems with referrals to 
specialist and payment for treatment. 
Second, the ACA mandates that insurance companies pay for an 
annual mammogram and cervical papanicolaou exam for women who are 
insured and underinsured. However, there are no mandates for 
treatment. It will be vital to have systems in place for the women who will 
be diagnosed and require treatment. Third, findings from this study 
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combined with health care system changes created by the ACA, suggest 
that more physicians and nurse practitioners are needed to provide 
treatment and follow up services for the increased demand of millions of 
uninsured women now becoming enrolled. This increased demand for 
services has the potential to reduce the time available for communication 
between patient and providers, which has the potential to cause further 
treatment delays. Finally, there are potential problems with timely access 
to care to treatment facilities. Some women who are eligible for the 
NBCCEDP program already have to wait for treatment services, because 
some sites, especially in rural areas, are already overwhelmed with 
patients due to provider shortages.  
 In spite of the expected increased access to care as a result of the 
ACA, there are women who will likely continue to face barriers with 
affordability, because their premium payments will exceed eight percent 
of their annual income (Rosenbaum, 2012). Furthermore, there may be 
breaks in enrollment coverage due to families experiencing fluctuations 
in their income for various reasons (Rosenbaum, 2012). Theses gaps in 
coverage during periods when a woman is actively undergoing diagnosis 
and treatment could potentially create challenges to achieving optimal 
outcomes. There is still the potential for African American women to 
continue experiencing delays in screening, diagnosis, and treatment as 
explained by Levy et al. (2012) because while the ACA eliminates cost 
sharing (co-pays) for cancer screening, low- income and moderate- 
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income women may still be unable to afford cost-sharing that remains in 
effect for diagnostic services after receiving an abnormal screening result.  
 Patient centered healthcare is another approach from the ACA 
(Rosenbaum, 2012). This study has raised the need for a more patient- 
centered approach in decision making in breast cancer centers. The 
current medical model is physician-centric and therefore care driven by 
the medical model. This is most evident in the current study (see 
Physician Communication). However, this study demonstrates the need 
to ensure that all women have the necessary tools to make informed 
decisions regarding their health care (Charles, 2004). A paradigm shift is 
need to ensure that physicians and other healthcare providers move 
toward a more collaborative approach to patient care, that is, to fully and 
meaningfully include patients in the plan of care, thus facilitating their 
decision making processes.    
Implications and Recommendations for Research 
 There are several recommendations for future research that arose 
from this study. Many of these proposed studies cover various aspects of 
the decision making process. It is imperative to add to the body of 
knowledge for African American women diagnosed with advanced breast 
cancer. The list below only covers a small sample of proposed studies.  
1. Communication interactions at various stages of treatment over time 
with healthcare providers.  
119 
 
 
 
 
2. The effects of time between diagnosis and actual treatment on decision 
making. 
3. The effects of family support on the decision making process. 
4. The effects of perceived body image on treatment decision making 
5. The effects of racism on physician trust and treatment decision 
making in African American women. 
6. Intimacy after having a mastectomy. 
7. An assessment of the different forms of cultural capital on treatment 
decision making.  
8. Interventional study on breast cancer survivor support on decision 
making and the level of involvement over time. 
9. Healthcare system and institutional barriers on the obtainment of 
timely diagnosis and treatment for African American women diagnosed 
with advanced stage breast cancer.  
Chapter Summary 
 This chapter provided an appraisal of the literature as it related to 
existing literature. Next, the results were discussed in relation to the 
conceptual framework. Then, the limitations of this study were discussed 
followed by implications for nursing practice. Finally, recommendations 
for future research were provided.  
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A Research Study on Treatment Decision 
Making with Breast Cancer 
 
Dauphne Sims, MS, RN, APN, CNS  
University of Wisconsin-Milwaukee 
Doctoral Student 
#9-815-543-7550 
Study approved by UWM IRB Protocol # 
 
1. I am a nurse doing research on decision making in African 
American women diagnosed with breast cancer.   
 
 
2.  The goal of this study is to learn how African American 
women make decisions about treatment.  
 
 
3. I would like to hear your story about how you made 
treatment decisions. This study will take about 1-2 hours of 
your time. 
 
 
4. If you would like to learn more about this study, please tell 
your nurse and I will call you. 
 
Thank You 
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Script: 
Hello my name is Dauphne Sims, I am a doctoral student in Nursing 
finishing my degree at the University of Wisconsin. Thanking you for 
taking the time to meet with me today. I have some questions I would 
like to ask you about your breast cancer diagnosis. 
Before we start I want to remind you that if you get tired, we can take as 
many breaks as you need during this interview. Also, if there are any 
questions you are not comfortable answering, just tell me you want to 
skip that question. Do you have any questions? 
Interview Guide 
1. What were you told about which type of breast cancer you have?  
 
2. Were you told which stage of breast cancer you have?  
 
3. What was it liked between you and your health care provider when 
you were told you had breast cancer? 
       a. Describe your feelings about your communication with your 
health care provider?  
 
4. Tell me about a time when you were not treated with respect by your 
doctors, nurses, or anyone else where you get treatment. 
 
5. How do you feel about talking to your health care providers about your 
breast cancer?   
 a. How much do you feel like you can really share your concerns 
with your health care provider? 
 
6. Do you feel you are treated different than other people where you get 
treatment?  
 If yes, how are you treated differently? If not, do you see others 
being treated differently? 
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7. A lot of women say that trust between them and their health care 
providers is important. Tell me about how much you trust your 
healthcare providers? 
 
8. Who made the decision about whether or not you would have 
treatment? 
 a. How comfortable were you with the treatment decisions that 
were made? 
 
9. Tell me about how you made decisions about which treatment 
methods to use? 
 
10. Tell me about the people who helped you with your treatment 
decisions.  
 a. How did they make your decision better or easier? 
 b. How did they make your decision worse or harder? 
 
11. What has your treatment been like?  
 
12. Please tell me about any side effects you have had with your 
treatment. 
  a. Were you told you could get these side effects prior to 
treatment? 
  b. Tell me how being in treatment has affected your life. 
 
13. Do you feel like the treatments that you have received are any 
different because of your race? If yes, how does this make you feel?  
 a. What have you tried to get around your being treated differently?  
14. How long did your healthcare provider tell you that you may live 
with/without treatment? 
 a. How often you discuss your cancer progress with your health 
care providers? 
 
b*What was the length of time between when you were told you have 
breast cancer to the time you had surgery? 
 
15. What money concerns do you have about treatment? 
 
16. What concerns do you have about paying for care and/or medicine?  
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17. Who has supported you with money since your diagnosis? 
 a. What other types of support do you get and who gives you that 
support? 
 b. Tell me about any spiritual support you get. 
 
18. Since you were diagnosed, what kind of talks do you have with your 
family or friends about your cancer? 
 
19. Other women tell me they do not feel like they know everything about 
their breast cancer is this true for you too? If yes, how? 
 a. If not, did you search for any additional information about your 
breast cancer? From where? 
 b. Please tell me about, any other technology or library resources 
you have used. 
20. If you could go back in time and change what you experienced, what 
would you change?  
 a. What do you know now that you wish you had known back 
when you were diagnosed or deciding on treatment?  
 
21. Tell me about any specific beliefs or personal values that were 
important to your treatment decisions. 
 
22. What treatment advice would you give to African American women 
who have just been diagnosed with breast cancer? 
 
23. What else do you want to share with me? 
 
24. What questions can I answer for you? 
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Decision Making in African 
American women Research 
Question Matrix 
 
Script: 
Hello my name is Dauphne Sims, I am 
a doctoral student in Nursing 
finishing my degree at the University 
of Wisconsin. Thanking you for taking 
the time to meet with me today. I have 
some questions I would like to ask you 
about your breast cancer diagnosis. 
Before we start I want to remind you 
that if you get tired, we can take as 
many breaks as you need during this 
interview. Also, if there are any 
questions you are not comfortable 
answering, just tell me you want to 
skip that question. Do you have any 
questions? 
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Research Questions Interview Guide Questions 
1. How do African American women 
describe the process of making 
decisions about breast cancer 
treatment? 
a. how do women participate in 
treatment decisions? 
 b. how is women’s participation 
in their treatment decisions 
facilitated? 
 c. how is women’s participation 
in their treatment decision hindered? 
 d. how do women describe their 
patient-health care provider 
 communication and interaction 
in relation to treatment decision 
making? 
 e. what additional resources do 
they utilize in making their treatment 
 decision? 
 
 
 
1. How were you told about which type of breast cancer you have?  
2. Were you told which stage of breast cancer you have?  
3. What was it liked between you and your health care provider 
when you were told you had breast cancer? 
       a. Describe your feelings about your communication with your 
health care provider?  
4. Tell me about a time when you were not treated with respect by 
your doctors, nurses, or anyone else where you get treatment. 
5. How do you feel about talking to your health care providers 
about your breast cancer?   
 a. How much do you feel like you can really share your 
concerns with your health care provider? 
7. A lot of women say that trust between them and their health 
care providers is important. Tell me about how much you trust 
your healthcare providers? 
8. Who made the decision about whether or not you would have 
treatment? 
          a. How comfortable were you with the treatment decisions 
that were made? 
9. Tell me about how you made decisions about which treatment 
methods to use? 
11. What has your treatment been like? 
12. Please tell me about any side effects you have had with your 
treatment. 
      a. Were you told you could get these side effects prior to 
treatment? 
      b. Tell me how being in treatment has affected your life. 
14. How long did your healthcare provider tell you that you may 
live with/without treatment? 
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 a. How often do you discuss your cancer progress with your 
health care providers? 
19. Other women tell me they do not feel like they know everything 
about their breast cancer is this true for you too? If yes, how? 
      a. If not, did you search for any additional information about 
your breast cancer? From where? 
      b. Please tell me about, any other technology or library 
resources you have used. 
20. If you could go back in time and change what you experienced, 
what would you change?  
     a. What do you know now that you wish you had known back 
when you were diagnosed or deciding on treatment?  
2. What cultural capital do women 
utilize when making treatment 
decisions? 
a. what social supports do women 
utilize when making treatment 
 decisions? 
 b. how do economic 
circumstances affect treatment 
decision making? 
 c. how do important cultural 
values or beliefs influence women 
when  making treatment decisions? 
 d. how do cultural concerns 
influence their treatment decisions? 
 
 
 
6. Do you feel you are treated different than other people where you 
get treatment? If yes, how are you treated differently? If not, do you 
see others being treated differently? 
10. Tell me about the people who helped you with your treatment 
decisions.  
     a. How did they make your decision better or easier? 
     b. How did they make your decision worse or harder? 
13. Do you feel like the treatments that you have received are any 
different because of your race? If yes, how does this make you feel?  
     a. What have you tried to get around your being treated 
differently?  
15. What money concerns do you have? 
16. What concerns do you have about paying for care and/or 
medicine?  
17. Who has supported you with money since your diagnosis? 
    a. What other types of support do you get and who gives you 
that support? 
    b. Tell me about any spiritual support you get. 
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21. Tell me about any specific beliefs or personal values that were 
important to your treatment decisions. 
18. Since you were diagnosed, what kind of talks do you have with 
your family or friends about your cancer? 
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Demographic Form 
Please check the boxes that best apply: 
How long ago were you diagnosed? 
 Less than 1 month ago                                               6 months ago 
 2 months ago                                                              7 months ago 
  3 months ago                                                             8 months ago 
 4 months ago                                                              9 months ago 
 5 months ago                                                              more than 1 year ago 
 
What type of treatments do you get? 
  I will start treatment soon 
 Chemotherapy  
 Radiation  
 Chemotherapy and Radiation  
 Other _______________  
How often do/did you get treatments? ___________________________________ 
 
What is your age? __________years           
 
Are you:                                            What type of medical coverage do you have? 
 Single                                                        Medicare   
 Married                                                    Medicaid 
  Widowed                                                Commercial (through employer) 
  Divorce                                                  None (self-pay)  
 Other______________                           Other________________________    
What is your annual household income before taxes?        What is your Zip code?________                       
  $0 - 20,000                                                            
  $21,000 - 40,000 
  $41,000- 60,000 
  $61,000-80,000    
  $81,000-100,000 
  over $100,000  
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Revised Interview Guide 
1. Tell me how you were you told about your breast cancer?  
 
2. Were you told which stage of breast cancer you have?  
 a. What type of breast cancer do you have?  
3. Describe your feelings about your communication with your health 
care provider?  
 
4. How much do you feel like you can really share your concerns with 
your health care provider? 
 
5.  A lot of women say that trust between them and their health care 
providers is important. Tell me about how much you trust your 
healthcare providers? 
 
6. Who made the decision about whether or not you would have 
treatment? 
 a. How comfortable were you with the treatment decisions that 
were made? 
 
7. Tell me about how you made decisions about which treatment 
methods to use? 
 a. What was the order of your treatment plan?    
 b. Tell me about the first step of your treatment plan. 
 c. What was next step? Etc. 
8. Before you let your physician know of your choices to whom did you 
speak with about your treatment decision(s)? 
 a. Women say that they thought it was important in their 
treatment decision to consider the way their body would look with or out 
their breast. Is this true for you? If so, tell me about it? 
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9. Tell me about the people who helped you with your treatment 
decisions.  
 a. How did they make your decision better or easier? 
 b. How did they make your decision worse or harder? 
 
10 What has your treatment been like?  
 
11. Please tell me about any side effects you have had with your 
treatment. 
  a. Were you told you could get these side effects prior to 
treatment? 
  b. Tell me how being in treatment has affected your life. 
 
12. Do you feel like the treatments that you have received are any 
different because of your race? If yes, how does this make you feel?  
 a. What have you tried to get around your being treated differently?  
13. How long did your healthcare provider tell you that you may live 
with/without treatment? 
 a. How often you discuss your cancer progress with your health 
care providers? 
 
14. What was the length of time between when you were told you have 
breast cancer to the time you had surgery? 
 
15. What money concerns do you have about treatment? 
 
16. What concerns do you have about paying for care and/or medicine?  
 
17. Who has supported you with money since your diagnosis? 
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 a. What other types of support do you get and who gives you that 
support? 
 b. Tell me about any spiritual support you get. 
 
18. Since you were diagnosed, what kind of talks do you have with your 
family or friends about your cancer? 
 
19. Other women tell me they do not feel like they know everything about 
their breast cancer is this true for you too? If yes, how? 
 a. prior to making your treatment decisions, did you search for any 
additional information about your breast cancer? From where? 
 b. Please tell me about, any other technology or library resources 
you have used. 
20. If you could go back in time and change what you experienced, what 
would you change?  
 a. What do you know now that you wish you had known back 
when you were diagnosed or deciding on treatment?  
21. When you think about your treatment what word(s) comes to mind 
that describe your experiences. 
 a. one the words I have heard is fortitude, does this word describe 
any of your experiences? If so, tell me how? 
 
22. Tell me about any specific beliefs or personal values that were 
important to your treatment decisions. 
 
23. What treatment advice would you give to African American women 
who have just been diagnosed with breast cancer? 
 
24. What else do you want to share with me? 
 
25. What questions can I answer for you? 
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CONFIRMABILITY STUDY 
 
TREATMENT DECISION MAKING IN AFRICAN AMERICAN WOMEN DIAGNOSED WITH 
ADVANCED BREAST CANCER 
  
I agree with the emerging concepts and theories that this grounded theory process 
uncovered.  The researcher has moved from substantive codes generated from the 
participants own words through more abstract leveled categories, ultimately resulting in 
the building blocks of theory.  Purposive and theoretical sampling along with 
simultaneous data collection and analysis yielded theories relevant to the data.  I do not 
believe any muddling of methods or compromise to grounded theory occurred.  
Beginning with open and selective coding, at each level, the theory became more refined 
yielding, what I believe was a parsimonious integration of abstract concepts that 
explained and covered the decision making process.  I recalled nothing to suggest 
premature closure or the inability to transcend the initial in vivo level of analysis; thus, 
the theories generated appear original.  A deeper understanding of concepts grew from 
the participants descriptive phrases.  
I believe combining interpersonal perceptiveness with conceptual thinking 
resulted in theoretical sensitivity.  Through the coding process, along with ongoing and 
constant revisions to the field notes and the mainstay of reflective journaling grounded 
the dependability of the data.  The discovery of “fortitude” as a major construct necessary 
to manage the myriad of challenges within the decision making process for women 
diagnosed with breast cancer, appears to played out at many interactional levels of 
experience for the women.  This study was credible in that it captured the essence of the 
treatment decision-making process of African American women diagnosed with 
advanced breast cancer. 
 
Thank you for the opportunity to offer this opinion. 
  
Sincerely,  
Dr. Thomas James Loveless, MSN, CRNP, PhD 
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Undergraduate admission and progression committee 2012-2013 
CCNE Subgroup B 2011-2013 
Academic Standards Committee 2004-2011 
Curriculum committee 2004-06 
Academic standards committee-Faculty Secretary 2006-2007 
Faculty Affairs-Chairperson 2006-2010 
Long Range Planning Committee 2006-2007 
Higher Learning Commission Subgroup A 2006-2007 
Sigma Theta Tau task force 2007-2008 
 
 
Scholarly Activities/Poster Presentations 
Presented at health care symposium; African American Women and Breast 
Cancer 
Poster Presentation on Health Disparities 
Abstract accepted for MNRS on post-partum fatigue in low income women. 
Presentation MNRS decision making in African American women diagnosed 
with breast cancer. 
Breast cancer presentations-Church group July 2012 
Doering, J. J. & Sims, D. A. (2010, June). Postpartum Fatigue in Lower-Income 
Urban Women with Depression Symptoms. SLEEP 2010 Annual Conference, San 
Antonio, TX. (peer reviewed). (poster). (national). 
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Sims April, 2010, Abstract for MNRS Pilot study of decision making in breast 
cancer of African American women. 
 
Mentoring:  
 Nursing Expo Spring 2014 Speaker Sheila Stanfield presentation titled 
“The have and have not’s of a colonoscopy” 
 
 Spring 2013: Graduate Student Melissa Fischer –Teaching Practicum; Saint 
Anthony College of Nursing 
Committee member with Char Sanford for Melissa Fischer:  Integrative literature 
review title: Effects of High-Fidelity Human Patient Simulation on Baccalaureate 
Nursing Student’s Confidence Levels and Critical Thinking Skills: An Integrated 
Literature Review 
 
 
 Fall 2013: Graduate Student for Deleon Addison- Teaching Practicum; 
Gonzaga University, Spokane, WA.     
 Hagenbruch, L. & Sims, D. (2014, March). Methods for improving patient trust in 
vaccinations. Poster presented at Nurses EXPO 2014, Rockford, IL. Winner of 
Best Student Poster Award. 
  
 
Publications  
Book Review 
Sims, D. (2002).  HIV a journey to the source of HIV and AIDS.  Leadership in 
Public Health, 5(3).  
Sims, D. ( 2007).  The special world of teaching. Perspective UIC College of Nursing, 
11(2). 
 
Unpublished Documents 
Masters Thesis: African American women and cervical and breast cancer  
Research: African American Women and Mammography: Who’s Being 
Screened? 
HLC Accreditation self study 2007 
CCNE Accreditation self study 2012 
 
Community Service  
Nursing Expo Program Committee 
Camp Nursing 
Parish Nursing 
American Cancer Society-making strides 
Scholarship 
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UWM Chancellor Award Scholarship 2007-2009 
Nursing Expo: Received a Doctoral Scholarship March 2012 
 
